https://www.pharmaceutical-business-review.com/uncategorized/avacta-glythera-collaborate-to-develop-alternatives-to-antibody-drug-conjugates-150716-4951229/ 2016-07-15T06:00:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/provectus-biopharmaceuticals-establishes-australian-subsidiary-150716-4951233/ 2016-07-15T06:03:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/promis-starts-new-program-to-find-novel-alzheimers-disease-targets-on-toxic-strains-of-protein-tau-150716-4951241/ 2016-07-15T06:06:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/eisai-and-arena-pharmaceuticals-secure-regulatory-approval-of-venespri-in-mexico-150716-4951249/ 2016-07-15T06:09:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/panther-biotechnology-starts-formal-development-of-transferrin-doxorubicin-conjugate-150716-4951259/ 2016-07-15T06:13:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/celgenes-revlimid-approved-in-europe-for-relapsed-or-refractory-mantle-cell-lymphoma-180716-4951884/ 2016-07-18T01:58:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/gsk-licenses-intellectual-property-for-respiratory-disease-target-identified-using-five-primes-platform180716-4952313/ 2016-07-18T05:35:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-issues-complete-response-letter-for-elites-sequestox-new-drug-application-180716-4952329/ 2016-07-18T05:41:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/synergy-pharmaceuticals-provides-update-on-fda-review-of-plecanatide-cic-nda-180716-4952350/ 2016-07-18T05:49:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ardelyx-agrees-to-raise-110m-in-private-placement-180716-4952382/ 2016-07-18T06:04:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fera-pharmaceuticals-and-oakwood-labs-announce-anda-approval-of-levothyroxine-sodium-for-injection-180716-4952386/ 2016-07-18T06:06:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/astrazenecas-tagrisso-meets-primary-endpoint-in-phase-iii-2nd-line-lung-cancer-trial-180716-4952414/ 2016-07-18T06:22:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-and-ema-accept-bristol-myers-filing-for-expanded-opdivo-indications-190716-4953204/ 2016-07-19T02:11:00+00:00 https://www.pharmaceutical-business-review.com/news/poxel-closes-265m-capital-increase-190716-4953670/ 2016-07-19T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/advanced-proteome-formulates-strategic-plan-featuring-novel-antibody-program-190716-4953688/ 2016-07-19T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-wins-fda-approval-fo-romeprazole-and-sodium-bicarbonate-capsules-20mg1100mg-190716-4953697/ 2016-07-19T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/eiger-doses-first-patient-in-phase-2-liberty-study-of-ubenimex-in-pulmonary-arterial-hypertension-190716-4953717/ 2016-07-19T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/tiziana-acquires-bio-repository-from-shardna-190716-4953778/ 2016-07-19T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/samsung-bioepis-humira-biosimilar-application-accepted-for-review-in-europe-190716-4953820/ 2016-07-19T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-astrazenecas-qtern-to-treat-type-2-diabetes-200716-4954720/ 2016-07-20T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/vernalis-achieves-milestone-in-oncology-drug-discovery-collaboration-with-servier-200716-4955036/ 2016-07-20T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/vbi-vaccines-applies-evlp-platform-to-develop-novel-vaccine-candidate-to-prevent-zika-virus-200716-4955054/ 2016-07-20T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/stellar-biotechnologies-neovacs-establish-new-company-in-france-200716-4955064/ 2016-07-20T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-expanded-label-for-namzaric-to-treat-moderate-to-severe-alzheimers-disease-200716-4955079/ 2016-07-20T05:57:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-approves-relistor-tablets-to-treat-oic-in-chronic-non-cancer-pain-adults-200716-4955107/ 2016-07-20T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/milliporesigma-starts-work-on-115m-life-science-campus-in-massachusetts-200716-4955154/ 2016-07-20T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/proqr-secures-fda-fast-track-designation-for-qr-010-to-treat-cystic-fibrosis-210716-4958076/ 2016-07-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-acquires-stake-in-chronos-therapeutics-210717-4955824/ 2016-07-21T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-grants-orphan-drug-designation-to-xoma-358-to-treat-congenital-hyperinsulinism-210716-4956364/ 2016-07-21T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/peptidream-licenses-pdps-technology-to-genentech-210716-4956392/ 2016-07-21T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/west-ward-pharmaceuticals-launches-generic-xeloda-tablets-150-mg-and-500-mg-in-us-210716-4956406/ 2016-07-21T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/sapience-therapeutics-signs-license-deal-with-columbia-university-for-novel-cancer-treatment-210716-4956429/ 2016-07-21T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/synthorx-raises-10m-to-develop-and-scale-novel-protein-therapeutics-210716-4956439/ 2016-07-21T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-apex-therapeutics-ind-for-clinical-testing-of-apx3330-in-pancreatic-cancer-210716-4956495/ 2016-07-21T06:29:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-zavicefta-meets-main-goals-in-phase-iii-trial-to-treat-hospital-acquired-pneumonia-220716-4957261/ 2016-07-22T01:55:00+00:00 https://www.pharmaceutical-business-review.com/news/scancell-appoints-eurogentec-scib1-material-manufacturer-220716-4957673/ 2016-07-22T05:06:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/chugai-galderma-sign-license-deal-for-nemolizumab-220617-4957707/ 2016-07-22T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/transgene-to-continue-phase-11b-study-with-tg1050-in-chronic-hepatitis-b-patients-220716-4957715/ 2016-07-22T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-provides-regulatory-update-on-bezlotoxumab-biologics-licensing-application-220716-4957728/ 2016-07-22T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-and-allergan-study-finds-biosimilar-comparable-to-roches-herceptin-breast-cancer-drug-220716-4957783/ 2016-07-22T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/inflarx-raises-34m-for-phase-ii-development-of-ifx-1-anti-complement-c5a-antibody-220716-4957830/ 2016-07-22T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/gileads-odefsey-emtricitabine-rilpivirine-tenofovir-alafenamide-meets-primary-objective-in-two-phase-3b-studies-220716-4958029/ 2016-07-22T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/synaffix-achieves-improved-therapeutic-index-compared-to-both-fda-approved-adcs-220716-4958040/ 2016-07-22T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/citron-pharma-launches-rosuvastatin-calcium-tablets-220716-4958050/ 2016-07-22T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/puma-submits-nda-for-pb272-to-fda-for-extended-adjuvant-treatment-of-her2-positive-early-stage-breast-cancer-220716-4958059/ 2016-07-22T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/european-chmp-adopts-positive-opinion-on-gileads-type-ii-variation-application-for-truvada-220716-4958116/ 2016-07-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-qidp-to-morphochems-intravenous-antibacterial-to-treat-c-difficile-infections-4958821/ 2016-07-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/european-chmp-recommends-shires-onivyde-to-treat-metastatic-adenocarcinoma-250716-4958974/ 2016-07-25T06:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-raises-concerns-over-valeants-new-ophthalmic-solution-250716-4959179/ 2016-07-25T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-bristol-myers-squibb-partner-on-combo-treatment-for-lung-cancer-260716-4959715/ 2016-07-26T02:08:00+00:00 https://www.pharmaceutical-business-review.com/news/vtesse-secures-17m-in-additional-series-a-funding-260716-4960247/ 2016-07-26T06:02:00+00:00 https://www.pharmaceutical-business-review.com/news/eiger-doses-first-patient-in-phase-2-study-of-ubenimex-in-secondary-lymphedema-260716-4960264/ 2016-07-26T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/just-biotherapeutics-secures-14m-series-a2-funding-260716-4960267/ 2016-07-26T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-lifts-clinical-hold-on-cgf166-260716-4960276/ 2016-07-26T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/tricida-raises-55m-for-kidney-disease-treatment-260716-4960314/ 2016-07-26T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/mercks-ebola-zaire-vaccine-gets-accelerated-review-designations-in-us-and-europe-260716-4960346/ 2016-07-26T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-janssen-collaborate-on-lung-cancer-treatment-270716-4961081/ 2016-07-27T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/quantum-pharma-launches-mucodis-rectal-gel-270716-4961543/ 2016-07-27T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/espada-acquires-glyderm-line-of-skin-care-products-from-lautus-pharmaceuticals-270716-4961564/ 2016-07-27T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/lsk-biopharma-announces-successful-outcome-from-end-of-phase-2-meeting-with-fda-for-apatinib-270716-4961582/ 2016-07-27T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/trek-therapeutics-acquires-two-antiviral-inhibitors-from-vertex-pharmaceuticals-270716-4961599/ 2016-07-27T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/recro-pharmas-iv-meloxicam-achieves-primary-endpoint-in-first-of-two-pivotal-trials-270717-4961689/ 2016-07-27T06:11:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/eisai-doses-first-patient-in-phase-1b2-clinical-trial-of-eribulin-in-combination-with-pegph20-270716-4961741/ 2016-07-27T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/us-ftc-approves-tevas-405bn-deal-for-allergans-generics-business-280716-4962436/ 2016-07-28T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/neurovances-centanafadine-adhd-drug-meets-main-goals-in-phase-2b-trial-4962886/ 2016-07-28T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/taurxs-lmtx-alzheimers-drug-fails-to-meet-co-primary-endpoints-in-phase-3-trial-4962950/ 2016-07-28T05:47:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/kite-pharma-announces-exclusive-license-with-nih-for-anti-cd19-car-product-candidate-280716-4962970/ 2016-07-28T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/vectura-initiates-legal-proceedings-against-glaxosmithkline-280716-4962990/ 2016-07-28T05:58:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/almirall-sun-pharma-sign-license-deal-to-develop-tildrakizumab-for-psoriasis-in-europe-280716-4963009/ 2016-07-28T06:04:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/hemispherx-signs-deal-with-avrio-biopharmaceuticals-for-accelerated-production-of-ampligen-280716-4963032/ 2016-07-28T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/shangai-fosun-to-buy-86-stake-in-gland-pharma-for-126bn-290716-4963889/ 2016-07-29T02:07:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-invest-275m-in-three-uk-manufacturing-sites-290716-4964054/ 2016-07-29T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-western-oncolytics-establish-immuno-oncology-research-collaboration-290716-4964421/ 2016-07-29T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/codexis-completes-obligations-under-research-and-development-deal-with-biopharmaceutical-firm-290716-4964427/ 2016-07-29T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-wins-fda-approval-of-adlyxin-to-treat-adults-with-type-2-diabetes-290716-4964443/ 2016-07-29T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/profil-institute-hightide-biopharmaceutical-partner-to-develop-new-therapies-for-diabetes-and-nafldnash-290716-4964456/ 2016-07-29T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/oxford-biomedica-secures-uk-mhra-approval-to-manufacture-drugs-at-new-facilities-290716-4964419/ 2016-07-29T05:57:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/european-commission-approves-mercks-zepatier-hepatitis-c-drug-010816-4965263/ 2016-08-01T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-crl-to-adma-biologics-bla-for-ri-002-010816-4965599/ 2016-08-01T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-neon-therapeutics-ind-for-cancer-vaccine-neo-pv-01-010816-4965637/ 2016-08-01T05:16:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ligand-signs-multi-program-ltp-technology-licensing-deal-with-nucorion-pharmaceuticals-010816-4965651/ 2016-08-01T05:22:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/xbrane-submits-gmp-approval-application-to-italys-aifa-for-production-facility-for-spherotide-010816-4965714/ 2016-08-01T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-acquires-gene-therapy-developer-bamboo-therapeutics-020816-4966714/ 2016-08-02T03:22:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/tetraphase-pharmaceuticals-starts-phase-1-clinical-trial-for-tp-6076-020816-4967114/ 2016-08-02T05:47:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/orexigen-signs-commercialization-deal-with-laboratorios-farmaceutico-for-mysimba-in-spain-020816-4967134/ 2016-08-02T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-to-offer-provantage-end-to-end-development-and-manufacturing-services-to-y-mabs-020816-4967150/ 2016-08-02T06:02:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/lymphoma-drug-adcetris-succeeds-in-phase-3-trial-020816-4967198/ 2016-08-02T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-lee011-breast-cancer-drug-gets-us-breakthrough-therapy-designation-030816-4968152/ 2016-08-03T03:13:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-secures-rights-to-advaxis-cancer-immunotherapy-treatment-030816-4968438/ 2016-08-03T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-sells-global-generics-business-to-teva-pharmaceuticals-030816-4968460/ 2016-08-03T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-adicet-bio-partner-to-discover-next-generation-engineered-immune-cell-therapeutics-030816-4968483/ 2016-08-03T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/avrobio-raises-25m-funding-to-advance-clinical-stage-gene-therapies-for-rare-diseases-030816-4968499/ 2016-08-03T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/mercks-keytruda-secures-european-approval-for-advanced-nsclc-040816-4969562/ 2016-08-04T02:20:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/pluristem-therapeutics-adopts-medidatas-cloud-technology-platform-040816-4969613/ 2016-08-04T03:34:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-to-buy-allergans-anda-distribution-business-for-500m-040816-4969975/ 2016-08-04T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/avara-to-buy-astellas-us-manufacturing-subsidiary-040816-4969990/ 2016-08-04T05:18:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-completes-safety-run-in-of-mor208-in-l-mind-combination-study-in-patients-with-dlbcl-040816-4970010/ 2016-08-04T05:24:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/dynavax-announces-fda-advisory-committee-meeting-to-review-heplisav-b-bla-050816-4972821/ 2016-08-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/eu-clears-sanofis-acquisition-of-boehringers-consumer-health-business-050816-4971058/ 2016-08-05T02:04:00+00:00 https://www.pharmaceutical-business-review.com/news/clinical-stage-biotechnology-firm-ambrx-closes-45m-round-of-financing-050816-4971426/ 2016-08-05T05:11:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/jacobs-wins-contract-for-alnylams-new-manufacturing-facility-in-massachusetts-050816-4971470/ 2016-08-05T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/juno-therapeutics-forms-multiple-myeloma-partnership-with-msk-and-eureka-therapeutics-4971501/ 2016-08-05T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committees-recommend-approval-of-egalets-abuse-deterrent-arymo-er-050816-4971597/ 2016-08-05T06:00:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/abbvie-files-patent-infringement-suit-over-amgens-copy-of-humira-drug-080816-4972437/ 2016-08-08T02:17:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/bristol-myers-opdivo-fails-to-meet-primary-endpoint-in-lung-cancer-study-080816-4972770/ 2016-08-08T05:23:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/teva-launches-generic-gleevec-tablets-in-us-080816-4972779/ 2016-08-08T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/scinopharm-cvie-therapeutics-to-jointly-develop-new-heart-failure-drug-080816-4972789/ 2016-08-08T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/lantern-pharma-signs-deal-to-evaluate-bionumeriks-tavocept-080816-4972803/ 2016-08-08T05:38:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/mylan-completes-meda-acquisition-080816-4972837/ 2016-08-08T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/helsinn-partners-with-mei-pharma-to-develop-pracinostat-cancer-drug-090816-4973896/ 2016-08-09T02:04:00+00:00 https://www.pharmaceutical-business-review.com/news/proteostasis-completes-preclinical-milestone-in-collaboration-with-astellas-pharma-090816-4973950/ 2016-08-09T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/akebia-starts-phase-3-program-to-evaluate-vadadustat-for-second-indication-in-renal-anemia-090816-4973959/ 2016-08-09T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/scintilla-pharmaceuticals-enters-into-binding-term-sheet-to-buy-scilex-pharmaceuticals-090816-4973968/ 2016-08-09T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-selumetinib-drug-fails-in-lung-cancer-trial-090816-4974362/ 2016-08-09T05:41:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/summit-therapeutics-to-include-new-formulation-of-dmd-treatment-ezutromid-in-phase-ii-trial-100816-4975499/ 2016-08-10T03:45:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ema-approves-single-dose-administration-of-cardiome-pharmas-xydalba-100816-4975748/ 2016-08-10T05:21:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/abeona-ebrp-and-eb-mrf-to-collaborate-on-epidermolysis-bullosa-treatments-100816-4975775/ 2016-08-10T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-pharmaceuticals-relaunches-generic-ofloxacin-otic-solution-100816-4975790/ 2016-08-10T05:33:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/moberg-pharma-gets-approvals-to-begin-phase-3-trial-for-mob-015-in-us-and-canada-100816-4975833/ 2016-08-10T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-invests-another-140m-in-moderna-therapeutics-110816-4976708/ 2016-08-11T03:08:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/genmab-signs-commercial-license-deal-with-gilead-for-duobody-technology-110816-4977028/ 2016-08-11T05:22:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/celsion-zhejiang-hisun-sign-deal-to-develop-gen-1-immuno-oncology-therapy-110816-4977064/ 2016-08-11T05:49:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/mallinckrodt-to-acquire-stratatech-110816-4977070/ 2016-08-11T05:52:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/lilly-to-continue-phase-3-abemaciclib-trial-despite-setback-110816-4977182/ 2016-08-11T06:49:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-approves-herons-sustol-for-chemotherapy-induced-nausea-and-vomiting-120816-4978118/ 2016-08-12T03:24:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/jacobs-wins-contract-for-novartis-pharma-biotechnology-center-expansion-in-france-120816-4978275/ 2016-08-12T05:21:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/inovio-expands-positive-phase-i-ebola-vaccine-trial-to-identify-most-optimal-immunization-regimen-120816-4978282/ 2016-08-12T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/nymox-unveils-major-progress-in-evidence-for-efficacy-of-prostate-drug-120816-4978286/ 2016-08-12T05:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ascendis-pharma-starts-phase-3-pediatric-ghd-study-120816-4978314/ 2016-08-12T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/acacia-pharma-unveils-positve-results-from-phase-3-trial-of-baremsis-to-treat-ponv-120816-4978403/ 2016-08-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/endo-decides-to-withdraw-snda-for-opana-er-120816-4978435/ 2016-08-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/arrowhead-pharmaceuticals-closes-45m-private-offering-120816-4978444/ 2016-08-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/molecular-flexibility-demonstrated-to-help-pharmaceutical-drugs-bind-to-their-targets-120816-4978508/ 2016-08-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-starts-trials-for-vision-loss-condition-drug-in-scotland-140816-4978683/ 2016-08-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/aurinias-voclosporin-meets-primary-endpoint-in-phase-2b-lupus-nephritis-trial-160816-4979449/ 2016-08-16T02:02:00+00:00 https://www.pharmaceutical-business-review.com/news/neurovive-pharmaceutical-completes-10-acquisition-of-isomerase-therapeutics-160816-4979535/ 2016-08-16T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-stops-phase-3-study-for-vx-661-in-combination-with-ivacaftor-to-treat-cystic-fibrosis-160816-4980141/ 2016-08-16T06:20:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/neurotrope-submits-amended-protocol-to-fda-for-phase-2-clinical-trial-of-bryostatin-1-160816-4980157/ 2016-08-16T06:24:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/tissue-regeneration-engineered-mesenchymal-stromal-cells-advance-monoclonal-antibody-therapy-160816-4980169/ 2016-08-16T06:28:00+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-starts-testing-new-hiv-treatment-1-4981138/ 2016-08-17T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/xycrobe-signs-research-deal-with-johnson-johnson-consumer-170816-4981610/ 2016-08-17T06:38:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/avacta-opens-two-new-facilities-in-cambridge-and-wetherby-170816-4981620/ 2016-08-17T06:41:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/eleven-biotherapeutics-completes-exclusive-licensing-deal-for-il-6-antagonist-antibody-technology-170816-4981626/ 2016-08-17T06:43:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/tioma-therapeutics-raises-86m-to-further-develop-antibody-portfolio-170816-4981692/ 2016-08-17T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/indiviors-opioid-treatment-study-of-rbp-6000-meets-primary-and-secondary-endpoints-170816-4981899/ 2016-08-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/wolters-kluwer-announces-sentri7-capabilities-for-direct-cda-automation-of-nhsn-reporting-4982853/ 2016-08-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mayne-pharma-acquires-tights-to-portfolio-of-dermatology-foam-products-4982859/ 2016-08-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fresenius-kabi-to-invest-250m-to-expand-pharmaceutical-manufacturing-facility-in-us-180816-4982489/ 2016-08-18T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/sasmar-acquires-aquatrove-biosciences-180816-4983062/ 2016-08-18T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/study-suggests-zika-virus-may-damage-adult-brain-190816-4983492/ 2016-08-19T01:44:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/teva-secures-european-approval-for-severe-asthma-drug-cinqaero-190816-4983521/ 2016-08-19T01:54:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/auris-medicals-ear-tinnitus-drug-keyzilen-fails-to-meet-co-primary-endpoints-in-phase-3-trial-190816-4983969/ 2016-08-19T06:00:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/caribou-biosciences-develops-new-method-to-profile-crispr-cas9-gene-editing-outcomes-190816-4983986/ 2016-08-19T06:05:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/xenetic-biosciences-partners-with-excivion-to-develop-novel-combined-zika-and-dengue-vaccine-190816-4983996/ 2016-08-19T06:09:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/portola-receives-complete-response-letter-from-fda-for-andexxa-bla-190816-4984011/ 2016-08-19T06:14:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-approves-pfizers-troxyca-er-extended-release-capsules-for-pain-management-220816-4984760/ 2016-08-22T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-and-crispr-therapeutics-jv-starts-operations-in-massachusetts-us-220816-4984908/ 2016-08-22T03:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ema-accepts-for-review-portolas-maa-for-indexxa-factor-xa-inhibitor-antidote-220816-4984924/ 2016-08-22T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/hemispherx-biopharma-forms-scientific-advisory-board-to-advice-on-drug-development-programs-220816-4984935/ 2016-08-22T03:43:00+00:00 https://www.pharmaceutical-business-review.com/news/supernus-secures-fda-tentative-approval-for-expanded-label-of-trokendi-xr-220816-4984955/ 2016-08-22T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/ds-biopharma-launches-spin-out-firm-focused-on-fibrotic-conditions-and-pulmonary-disorders-220816-4984967/ 2016-08-22T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-acquire-medivation-for-14bn-230816-4985910/ 2016-08-23T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/4d-pharma-starts-dosing-in-phase-1-trial-with-thetanix-to-treat-paediatric-crohns-disease-230816-4986354/ 2016-08-23T05:25:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ema-validates-puma-biotechnologys-maa-for-neratinib-230816-4986368/ 2016-08-23T05:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ec-grants-marketing-authorization-for-gileads-once-daily-truvada-for-reducing-risk-of-sexually-acquired-hiv-1-4986385/ 2016-08-23T05:36:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/astrazeneca-and-eli-lilly-secure-fda-fast-track-status-for-alzheimers-drug-230816-4986430/ 2016-08-23T05:54:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/janssen-seeks-eu-approval-for-extended-use-of-darzalex-240816-4987299/ 2016-08-24T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-chooses-veeva-vault-to-streamline-submissions-etmf-and-quality-management-240816-4987485/ 2016-08-24T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/marken-secures-new-pharmaceutical-license-for-moscow-depot-240816-4987502/ 2016-08-24T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-secures-tentative-fda-approval-for-generic-version-of-suprep-oral-solution-240816-4987526/ 2016-08-24T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-to-clovis-rucaparib-for-advanced-brca-mutated-ovarian-cancer-240816-4987615/ 2016-08-24T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-baf312-meets-main-goal-in-secondary-progressive-multiple-sclerosis-trial-250816-4988439/ 2016-08-25T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/evgen-pharma-gets-fda-orphan-drug-designation-for-stabilised-sulforaphane-250816-4988470/ 2016-08-25T02:46:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/biothera-collaborattes-with-merck-for-combination-cancer-immunotherapy-trials-in-multiple-indications-250816-4988482/ 2016-08-25T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/insys-reports-phase-3-trial-of-sublingual-buprenorphine-spray-meets-primary-endpoint-250816-4988545/ 2016-08-25T03:50:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/astrazeneca-to-sell-part-of-antibiotics-business-to-pfizer-in-16bn-deal-250816-4988769/ 2016-08-25T05:39:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/f-star-denali-therapeutics-partner-to-develop-multispecific-antibody-platform-260816-4989714/ 2016-08-26T03:51:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-issues-complete-response-letter-for-amgens-nda-for-parsabiv-260816-4989866/ 2016-08-26T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-and-i-bridge-capital-establish-drug-development-jv-in-china-260816-4989879/ 2016-08-26T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/highland-therapeutics-subsidiary-starts-phase-2-trial-for-hld100-in-pediatric-adhd-patients-260816-4989890/ 2016-08-26T05:17:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/european-medical-agency-to-review-mylan-and-biocons-anti-cancer-biosimilar-260816-4989990/ 2016-08-26T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/neuroderm-starts-phase-iii-trial-of-ndo612l-in-parkinsons-disease-290816-4990653/ 2016-08-29T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/mallinckrodts-dmd-drug-receives-fda-fast-track-designation-290816-4991051/ 2016-08-29T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-recalls-one-lot-of-lamotrigine-orally-disintegrating-tablet-200-mg-290816-4991093/ 2016-08-29T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/birchbiomed-completes-anti-scarring-drug-clinical-trial-290816-4991116/ 2016-08-29T05:05:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/taigen-out-licenses-taigexyn-to-productos-cientificos-for-latin-american-market-290816-4991139/ 2016-08-29T05:14:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/bioinvent-extends-manufacturing-services-contract-with-global-pharmaceutical-client-290816-4991561/ 2016-08-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/alexion-pharmaceuticals-alxn1007-secures-eu-orphan-drug-status-310816-4993407/ 2016-08-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cti-biopharma-reports-mixed-results-for-pacritinib-in-advanced-myelofibrosis-300816-4991928/ 2016-08-30T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-unveils-positive-results-from-phase-3-study-of-prolia-in-patients-receiving-glucocorticoid-therapy-300816-4992053/ 2016-08-30T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/tonix-announces-successful-end-of-phase-2-meeting-with-fda-for-tnx-102-sl-in-ptsd-300816-4992068/ 2016-08-30T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/rigels-fostamatinib-meets-main-goal-in-phase-3-study-in-chronic-itp-310816-4993097/ 2016-08-31T03:26:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/compugen-enhances-links-computational-platform-310816-4993308/ 2016-08-31T05:34:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ariad-completes-rolling-submission-of-nda-for-brigatinib-to-fda-310816-4993313/ 2016-08-31T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/oncomed-completes-patient-enrollment-in-phase-2-trial-of-tarextumab-in-sclc-310816-4993329/ 2016-08-31T05:43:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-approves-sandozs-enbrel-biosimilar-for-multiple-inflammatory-diseases-310816-4993389/ 2016-08-31T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-xalkori-gets-european-approval-for-ros1-positive-advanced-nsclc-010916-4994151/ 2016-09-01T02:03:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-calls-for-boxed-warnings-on-two-drug-classes-010916-4994382/ 2016-09-01T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-and-adamas-settle-namzaric-patent-litigation-with-amneal-010916-4994404/ 2016-09-01T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-launches-largest-pharmaceutical-company-sponsored-multiple-myeloma-study-010916-4994421/ 2016-09-01T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/caisson-biotech-seeks-buyer-for-heptune-drug-delivery-platform-4994433/ 2016-09-01T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/singapore-sees-first-case-of-pregnant-woman-with-zika-virus-010916-4994589/ 2016-09-01T05:51:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/biogens-alzheimers-drug-gets-fda-fast-track-status-020916-4995368/ 2016-09-02T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-amgens-blincyto-for-pediatric-acute-lymphoblastic-leukemia-020916-4995558/ 2016-09-02T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/crescita-therapeutics-acquires-intega-skin-sciences-020916-4995567/ 2016-09-02T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/genentechs-tecentriq-improves-survival-in-phase-iii-lung-cancer-study-020916-4995578/ 2016-09-02T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-gets-financial-support-from-us-to-develop-zika-vaccine-020916-4995641/ 2016-09-02T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/aeterna-zentaris-announces-two-new-licensing-deals-for-zoptrex-020916-4995757/ 2016-09-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/galenica-completes-acquisition-of-relypsa-020916-4995788/ 2016-09-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/taiho-ventures-invests-in-arcus-biosciences-020916-4995817/ 2016-09-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-discontinues-osteoporosis-drug-development-on-increased-risk-of-stroke-02-4995960/ 2016-09-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/astrazenecas-benralizumab-meets-main-goals-in-phase-iii-trials-for-severe-asthma-060916-4996720/ 2016-09-06T03:37:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/dynavax-says-pdufa-date-for-heplisav-b-remains-unchanged-060916-4996746/ 2016-09-06T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/destiny-pharmas-xf-73-anti-bacterial-drug-delivers-encouraging-data-in-us-clinical-trial-060916-4997178/ 2016-09-06T06:28:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/dr-reddys-laboratories-launches-bupropion-hcl-extended-release-tablets-usp-sr-in-us-060916-4997194/ 2016-09-06T06:33:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-grants-orphan-drug-status-to-catalyst-pharmaceuticals-firdapse-for-myasthenia-gravis-060916-4997211/ 2016-09-06T06:36:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-discovery-fulcrum-partner-for-novel-crispr-based-target-discovery-in-genetic-diseases-070916-4998360/ 2016-09-07T04:11:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-accepts-ccp-07-new-drug-application-for-full-review-070916-4998649/ 2016-09-07T05:43:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/redx-signs-deal-with-quay-pharma-to-manufacture-clinical-trial-supplies-for-porcupine-inhibitor-070916-4998671/ 2016-09-07T05:49:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/aerie-submits-nda-to-fda-for-rhopressa-netarsudil-ophthalmic-solution-002-070916-4998692/ 2016-09-07T05:55:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/avara-to-buy-astrazenecas-uk-manufacturing-facility-070916-4998709/ 2016-09-07T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/tonix-to-discontinue-development-of-tnx-102-sl-for-fibromyalgia-070916-4998764/ 2016-09-07T06:19:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/mercks-keytruda-wins-fda-breakthrough-therapy-status-priority-review-for-first-line-nsclc-080916-4999795/ 2016-09-08T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-bms-orencia-for-methotrexate-naive-ra-patients-080916-5000080/ 2016-09-08T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-starts-global-phase-3-trial-of-dengue-vaccine-candidate-tak-003-080916-5000110/ 2016-09-08T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/immupharma-to-open-site-in-mauritius-for-trial-of-lupus-treatment-080916-5000129/ 2016-09-08T06:01:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/retrophins-sparsentan-succeeds-in-phase-2-study-in-rare-kidney-disorder-080916-5000205/ 2016-09-08T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/ergomed-completes-patient-recruitment-for-insomnia-drug-trial-090916-5001063/ 2016-09-09T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/diabetes-startup-antolrx-secures-funding-from-pfizer-jdrf-and-orion-equity-090916-5001245/ 2016-09-09T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/emmaus-life-sciences-submits-nda-to-fda-for-sickle-cell-disease-treatment-090916-5001260/ 2016-09-09T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/gtx-achieves-stage-1-milestone-in-phase-2-trial-of-enobosarm-in-erar-breast-cancer-090916-5001275/ 2016-09-09T05:03:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-grants-orphan-drug-status-to-ovids-ov101-for-genetic-neurologic-disorder-090916-5001364/ 2016-09-09T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-introduces-new-gene-editing-technology-to-modify-cho-cell-lines-090916-5001707/ 2016-09-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-scientific-opens-new-clinical-services-facility-in-south-korea-090916-5001852/ 2016-09-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/singapore-confirms-eight-pregnant-women-among-329-zika-infected-120916-5008769/ 2016-09-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-verily-life-sciences-create-new-jv-to-develop-diabetes-management-platform-120916-5002231/ 2016-09-12T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-and-janssen-seek-european-approval-for-sirukumab-in-rheumatoid-arthritis-130916-5003534/ 2016-09-13T03:34:00+00:00 https://www.pharmaceutical-business-review.com/news/epam-sinequa-partner-to-address-cognitive-search-analytics-challenges-in-pharma-industry-130916-5003892/ 2016-09-13T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/ember-therapeutics-to-buy-dermasilk-brands-130916-5003913/ 2016-09-13T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/xencor-doses-first-patient-in-phase-1-clinical-trial-of-xmab14045-130916-5003931/ 2016-09-13T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/macrogenics-regains-global-rights-to-dart-molecule-for-autoimmune-disorders-130916-5003953/ 2016-09-13T06:15:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/foamixs-fmx103-meets-efficacy-endpoints-in-phase-2-trial-for-papulopustular-rosacea-130916-5003992/ 2016-09-13T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-cabometyx-tablets-to-treat-advanced-rcc-following-vegf-targeted-therapy-140916-5004978/ 2016-09-14T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-discovery-licenses-biomanufacturing-cell-lines-to-cpi-and-nibrt-140916-5005096/ 2016-09-14T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-launches-two-new-phase-iiib-trials-for-forxiga-140916-5005130/ 2016-09-14T05:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/alliance-pharma-secures-rights-to-pregnancy-nausea-drug-in-key-eu-countries-5005140/ 2016-09-14T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/catalent-agrees-to-buy-pharmatek-laboratories-140916-5005287/ 2016-09-14T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-to-buy-vitae-pharmaceuticals-for-639m-150916-5005829/ 2016-09-14T23:38:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-launches-app-to-help-patients-manage-depression-150916-5005845/ 2016-09-14T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-secures-fda-approval-for-primary-immunodeficiency-drug-150916-5006010/ 2016-09-15T00:54:00+00:00 https://www.pharmaceutical-business-review.com/news/aerie-pharmaceuticals-eye-drug-meets-main-goal-in-phase-3-trial-150916-5006031/ 2016-09-15T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/gsks-shingles-vaccine-remains-effective-after-four-years-in-phase-iii-study-150916-5006086/ 2016-09-15T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-and-pfizers-diabetes-treatment-meets-primary-endpoint-in-phase-3-trial-160916-5007117/ 2016-09-16T02:38:00+00:00 https://www.pharmaceutical-business-review.com/news/aralezs-yosprala-gets-fda-approval-for-secondary-cv-prevention-160916-5007425/ 2016-09-16T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/xencor-starts-phase-1b-trial-of-subcutaneous-formulation-of-xmab7195-160916-5007452/ 2016-09-16T05:45:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/peloton-therapeutics-completes-524m-series-d-financing-round-160916-5007465/ 2016-09-16T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/novavaxs-respiratory-disease-vaccine-fails-in-phase-3-trial-160916-5007525/ 2016-09-16T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/emas-chmp-recommends-approval-for-three-new-cancer-drugs-190916-5008417/ 2016-09-19T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/ligand-pharmaceuticalsm-signs-omniab-license-deal-with-teneobio-190916-5008612/ 2016-09-19T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-expands-collaboration-with-amgen-in-india-190916-5008636/ 2016-09-19T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/aerie-pharmaceuticals-raises-125m-in-public-offerings-190916-5008663/ 2016-09-19T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-diabetes-drug-combination-meets-main-goals-in-phase-iii-study-190916-5008853/ 2016-09-19T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-opens-new-development-and-commercial-hub-in-maidenhead-uk-200916-5010049/ 2016-09-20T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/redx-pharma-confirms-potential-role-for-porcupine-inhibitor-in-cancer-immunotherapy-200916-5010066/ 2016-09-20T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/cynata-therapeutics-secures-uk-mhra-approval-for-gvhd-clinical-trial-200916-5010098/ 2016-09-20T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-sarepta-therapeutics-duchenne-muscular-dystrophy-drug-200916-5010111/ 2016-09-20T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-files-patent-infringement-suit-against-merck-200916-5010232/ 2016-09-20T05:44:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/allergan-to-acquire-tobira-therapeutics-in-17bn-deal-210916-5011234/ 2016-09-21T03:52:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-validates-bms-type-ii-variation-application-for-opdivo-in-advanced-form-of-bladder-cancer-210916-5011455/ 2016-09-21T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-names-emma-walmsley-as-new-ceo-210916-5011483/ 2016-09-21T05:49:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/midatech-pharma-us-partnersh-with-r-pharm-us-to-co-promote-zuplenz-and-oravig-210916-5011500/ 2016-09-21T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-evotec-join-hands-to-develop-new-treatments-for-kidney-diseases-210916-5011590/ 2016-09-21T06:28:00+00:00 https://www.pharmaceutical-business-review.com/news/facebooks-mark-zuckerberg-announces-3bn-funding-to-help-cure-diseases-5012395/ 2016-09-22T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/turing-advances-several-experimental-compounds-into-pre-clinical-development-220916-5012600/ 2016-09-22T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-selects-llamasoft-as-supply-chain-design-technology-partner-220916-5012654/ 2016-09-22T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-affilogic-partner-to-develop-cns-therapies-220916-5012673/ 2016-09-22T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-janssens-new-type-2-diabetes-combination-therapy-220916-5012804/ 2016-09-22T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/tevas-second-phase-iii-study-of-sd-809-in-td-shows-statistically-significant-results-230916-5013783/ 2016-09-23T03:45:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/uks-nice-supports-restricted-use-of-alexion-pharmaceuticals-strensiq-230916-5014086/ 2016-09-23T06:07:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/sanarias-preventative-vaccine-for-malaria-gets-fda-fast-track-designation-230916-5014094/ 2016-09-23T06:12:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/evotec-forms-research-collaboration-with-inserm-transfert-in-oncology-230916-5014104/ 2016-09-23T06:15:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ligand-pharmaceuticals-licensing-deals-with-seelos-therapeutics-for-four-programs-230916-5014119/ 2016-09-23T06:22:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-expanded-use-of-novartis-ilaris-to-treat-three-rare-periodic-fever-syndromes-260916-5014750/ 2016-09-26T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-biotech-files-us-regulatory-application-for-sirukumab-in-rheumatoid-arthritis-260916-5014980/ 2016-09-26T04:52:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/biolinerx-in-licenses-novel-treatment-for-liver-failure-conditions-260916-5015006/ 2016-09-26T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/erytech-completes-patient-enrollment-in-phase-2-trial-of-eryaspase-for-pancreatic-cancer-260916-5015062/ 2016-09-26T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaron-enters-into-non-binding-heads-of-terms-with-msd-over-hoddesdon-uk-site-260916-5015084/ 2016-09-26T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-scraps-plan-to-split-into-two-companies-270916-5016048/ 2016-09-27T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/parexel-agrees-to-acquire-execupharm-270916-5016269/ 2016-09-27T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-secures-43m-us-funding-to-spur-zika-vaccine-development-270916-5016290/ 2016-09-27T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharmaceuticals-unveils-second-positive-phase-3-trial-for-epidiolex-in-lgs-treatment-270916-5016334/ 2016-09-27T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-janssen-biotechs-stelara-for-crohns-disease-270916-5016347/ 2016-09-27T05:12:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/kite-pharmas-lead-cancer-drug-shows-encouraging-results-270916-5016556/ 2016-09-27T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/0b4b1hana_acquires_anticancer_compounds_from/ 2018-07-04T12:11:07+00:00 https://www.pharmaceutical-business-review.com/news/88484basilea_and_jj_seek_broader_indication_for_antib/ 2018-07-04T12:22:58+00:00 https://www.pharmaceutical-business-review.com/news/b5480spectrum_initiates_trial_of_prostate_cancer/ 2018-07-04T12:28:27+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-gets-uspto-issuance-of-additional-notice-of-allowance-with-claims-covering-pennsaid-2-060715-4616305/ 2018-07-04T12:32:36+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-expands-taneds-collaborative-drug-discovery-program-in-europe-020914-4359465/ 2018-07-04T13:03:05+00:00 https://www.pharmaceutical-business-review.com/news/covance-and-business-review-free-webinar-4220798/ 2018-07-04T13:38:24+00:00 https://www.pharmaceutical-business-review.com/news/c8498pozen_and_astrazeneca_begin_phase_iii_osteoarthritis_drug_/ 2018-07-04T14:11:48+00:00 https://www.pharmaceutical-business-review.com/news/c3498pharmasset_says_hepatitis_c_drug_meets_trial_/ 2018-07-04T14:11:48+00:00 https://www.pharmaceutical-business-review.com/news/14484kosan_breast_cancer_drug_performs_well_in_phase_i_/ 2018-07-04T14:11:48+00:00 https://www.pharmaceutical-business-review.com/news/d6482actavis_challenges_king_pharmaceuticalss_pain_drug_p/ 2018-07-04T14:11:49+00:00 https://www.pharmaceutical-business-review.com/news/964b4antidepressant_may_help_in_dementia_researchers/ 2018-07-04T14:11:49+00:00 https://www.pharmaceutical-business-review.com/news/974a3xtl_advances_pain_drug_to_phas/ 2018-07-04T14:11:49+00:00 https://www.pharmaceutical-business-review.com/news/13491crucell_grants_merck__co_access_to_vaccine_techn/ 2018-07-04T14:11:49+00:00 https://www.pharmaceutical-business-review.com/news/bd484us_court_temporarily_stops_teva_from_marketing_generic_f/ 2018-07-04T14:11:50+00:00 https://www.pharmaceutical-business-review.com/news/d3493abbott_starts_diabetic_pain_drug_/ 2018-07-04T14:11:50+00:00 https://www.pharmaceutical-business-review.com/news/db494medimmune_resolves_flumist_manufacturing_i/ 2018-07-04T14:11:50+00:00 https://www.pharmaceutical-business-review.com/news/ef4b2genmab_reports_encouraging_preclinical_data_for_ofatu/ 2018-07-04T14:12:25+00:00 https://www.pharmaceutical-business-review.com/news/7b481idera_results_support_cancer_drug_combin/ 2018-07-04T14:12:26+00:00 https://www.pharmaceutical-business-review.com/news/1c48dintrogen_to_start_trial_for_cancer_immunotherap/ 2018-07-04T14:12:26+00:00 https://www.pharmaceutical-business-review.com/news/3c4b8aradigm_and_cydex_collaborate_on_respiratory_res/ 2018-07-04T14:12:26+00:00 https://www.pharmaceutical-business-review.com/news/f249eosi_reports_positive_diabetes_treatment_study_re/ 2018-07-04T14:12:26+00:00 https://www.pharmaceutical-business-review.com/news/4e485alpharma_licenses_pain_product_from/ 2018-07-04T14:12:27+00:00 https://www.pharmaceutical-business-review.com/news/714bbmercks_lung_cancer_drug_performs_well_in_phase_ii_/ 2018-07-04T14:12:27+00:00 https://www.pharmaceutical-business-review.com/news/87483american_oriental_bioengineering_buys_changchun_/ 2018-07-04T14:12:27+00:00 https://www.pharmaceutical-business-review.com/news/4d4a9cell_therapeutics_to_conduct_full_analysis_of_pixantrone_/ 2018-07-04T14:12:27+00:00 https://www.pharmaceutical-business-review.com/news/e34b4zealand_starts_chemotherapy_drug_/ 2018-07-04T14:12:27+00:00 https://www.pharmaceutical-business-review.com/news/a84bdkosan_agrees_phase_iii_trial_design_wit/ 2018-07-04T14:12:28+00:00 https://www.pharmaceutical-business-review.com/news/46491fda_wants_extra_study_for_encysives_t/ 2018-07-04T14:12:29+00:00 https://www.pharmaceutical-business-review.com/news/6349fpfizer_to_study_sutent_in_combination_with_ta/ 2018-07-04T14:12:29+00:00 https://www.pharmaceutical-business-review.com/news/1b4a8atherogenics_heart_drug_has_minor_effect_on_diab/ 2018-07-04T14:12:29+00:00 https://www.pharmaceutical-business-review.com/news/7d4a2poniard_gets_fast_track_designation_for_lung_cancer_trea/ 2018-07-04T14:12:29+00:00 https://www.pharmaceutical-business-review.com/news/364bfakela_reports_positive_results_for_fentanyl_taifun_/ 2018-07-04T14:12:29+00:00 https://www.pharmaceutical-business-review.com/news/ad48cnovartis_drug_gets_eu_approval_to_treat_hospital_infec/ 2018-07-04T14:12:30+00:00 https://www.pharmaceutical-business-review.com/news/ff485evotec_reports_strong_phase_ii_results_for_insomnia/ 2018-07-04T14:12:30+00:00 https://www.pharmaceutical-business-review.com/news/604adpfizer_warns_of_dangers_in_switching_from_li/ 2018-07-04T14:12:30+00:00 https://www.pharmaceutical-business-review.com/news/b34beardea_biosciences_says_phase_i_hiv_drug_trial_su/ 2018-07-04T14:12:30+00:00 https://www.pharmaceutical-business-review.com/news/8d4aaprovectus_gains_approval_for_phase_ii_provecta_t/ 2018-07-04T14:12:32+00:00 https://www.pharmaceutical-business-review.com/news/bb498antisoma_reports_positive_results_in_cancer_drug_/ 2018-07-04T14:12:32+00:00 https://www.pharmaceutical-business-review.com/news/e0493ovation_initiates_phase_iii_epilepsy_/ 2018-07-04T14:12:33+00:00 https://www.pharmaceutical-business-review.com/news/eurand_receives_1_5_million_milestone_from_gsk/ 2018-07-04T14:12:33+00:00 https://www.pharmaceutical-business-review.com/news/e94bcfda_accepts_scieles_reformulated_heart_drug_for_r/ 2018-07-04T14:12:33+00:00 https://www.pharmaceutical-business-review.com/news/2549agtc_drug_receives_fast_track_s/ 2018-07-04T14:12:33+00:00 https://www.pharmaceutical-business-review.com/news/f94bdbiovails_pain_drug_formulation_approved_in_c/ 2018-07-04T14:12:33+00:00 https://www.pharmaceutical-business-review.com/news/98494clinical_data_sees_positive_results_from_pivotal_depression_drug_/ 2018-07-04T14:12:34+00:00 https://www.pharmaceutical-business-review.com/news/8548dym_biosciences_lung_cancer_drug_shows_pr/ 2018-07-04T14:12:34+00:00 https://www.pharmaceutical-business-review.com/news/c5498watson_receives_fda_product_approval_for_india_fac/ 2018-07-04T14:12:34+00:00 https://www.pharmaceutical-business-review.com/news/cc4aeshire_partially_withdraws_adhd_/ 2018-07-04T14:12:35+00:00 https://www.pharmaceutical-business-review.com/news/b54a3jerini_regains_rights_to_icatibant_from_a/ 2018-07-04T14:12:35+00:00 https://www.pharmaceutical-business-review.com/news/934bcmerck_applies_to_extend_use_of_erbitux_for_colorectal_c/ 2018-07-04T14:12:35+00:00 https://www.pharmaceutical-business-review.com/news/0049bpharmexa_loses_european_patent_a/ 2018-07-04T14:12:36+00:00 https://www.pharmaceutical-business-review.com/news/8c4b5eu_asked_to_investigate_british_drug_lo/ 2018-07-04T14:12:36+00:00 https://www.pharmaceutical-business-review.com/news/0348bponiard_reports_positive_phase_ii_lung_cancer_drug_re/ 2018-07-04T14:12:36+00:00 https://www.pharmaceutical-business-review.com/news/b94aeoral_cancer_drug_revlimid_gets_swissmedic_app/ 2018-07-04T14:12:36+00:00 https://www.pharmaceutical-business-review.com/news/f44bechemotherapy_drug_aloxi_gets_label_c/ 2018-07-04T14:12:36+00:00 https://www.pharmaceutical-business-review.com/news/0449aisis_starts_study_of_type_ii_diabetes/ 2018-07-04T14:12:37+00:00 https://www.pharmaceutical-business-review.com/news/b94a2encysive_completes_patient_enrollment_for_heart_failure_/ 2018-07-04T14:12:37+00:00 https://www.pharmaceutical-business-review.com/news/2b4a5blood_pressure_pill_cuts_diabetics_death_rate_study_/ 2018-07-04T14:12:38+00:00 https://www.pharmaceutical-business-review.com/news/894bftibotec_returns_hbv_drug_licensing_rights_to_me/ 2018-07-04T14:12:38+00:00 https://www.pharmaceutical-business-review.com/news/43496speedel_heart_drug_promising_in_pha/ 2018-07-04T14:12:39+00:00 https://www.pharmaceutical-business-review.com/news/154aegsks_arixtra_gets_eu_approval_for_extra_indic/ 2018-07-04T14:12:39+00:00 https://www.pharmaceutical-business-review.com/news/66484study_confirms_efficacy_of_a/ 2018-07-04T14:12:39+00:00 https://www.pharmaceutical-business-review.com/news/76496encouraging_results_for_eli_lillys_schizophrenia/ 2018-07-04T14:12:39+00:00 https://www.pharmaceutical-business-review.com/news/8d497actelion_reports_positive_results_for_insomnia/ 2018-07-04T14:12:39+00:00 https://www.pharmaceutical-business-review.com/news/29483study_sheds_light_on_cancer_drug_mech/ 2018-07-04T14:12:40+00:00 https://www.pharmaceutical-business-review.com/news/93489fda_approves_acambis_smallpox_va/ 2018-07-04T14:12:40+00:00 https://www.pharmaceutical-business-review.com/news/f4491obecure_obesity_drug_shows_strong_results_in_/ 2018-07-04T14:12:40+00:00 https://www.pharmaceutical-business-review.com/news/5e486fda_report_supports_merck_hiv_drug_app/ 2018-07-04T14:12:41+00:00 https://www.pharmaceutical-business-review.com/news/c8481sanofiaventis_reports_positive_study_results_for_lo/ 2018-07-04T14:12:41+00:00 https://www.pharmaceutical-business-review.com/news/ac495abbott_and_astrazeneca_advance_combination_heart/ 2018-07-04T14:12:41+00:00 https://www.pharmaceutical-business-review.com/news/ab4b1merck_reports_encouraging_results_in_pivotal_heart_drug_/ 2018-07-04T14:12:42+00:00 https://www.pharmaceutical-business-review.com/news/b44aaprostate_cancer_drug_eligard_gets_new_european_dosage_app/ 2018-07-04T14:12:42+00:00 https://www.pharmaceutical-business-review.com/news/60481cardiome_and_astellas_to_meet_with_fda_panel_over_heart/ 2018-07-04T14:12:42+00:00 https://www.pharmaceutical-business-review.com/news/254a9kiadis_pharmas_reviroc_shows_potential_in_phase_ii_/ 2018-07-04T14:12:42+00:00 https://www.pharmaceutical-business-review.com/news/9a491ym_biosciences_cleared_to_start_brain_tumor_/ 2018-07-04T14:12:43+00:00 https://www.pharmaceutical-business-review.com/news/80484opko_starts_pivotal_eye_drug_/ 2018-07-04T14:12:43+00:00 https://www.pharmaceutical-business-review.com/news/98494pharming_genetic_disorder_drug_meets_trial_/ 2018-07-04T14:12:43+00:00 https://www.pharmaceutical-business-review.com/news/e749ealzheimers_drug_successful_in_phase_i_says_trans/ 2018-07-04T14:12:44+00:00 https://www.pharmaceutical-business-review.com/news/8648bfda_accepts_mercks_cholesterol_drug_for_r/ 2018-07-04T14:12:45+00:00 https://www.pharmaceutical-business-review.com/news/b04b5lorus_takes_leukemia_drug_to_pha/ 2018-07-04T14:12:45+00:00 https://www.pharmaceutical-business-review.com/news/a94a2pharmions_oral_vidaza_granted_fast_track_s/ 2018-07-04T14:12:45+00:00 https://www.pharmaceutical-business-review.com/news/21482prolexys_begins_clinical_trials_for_cancer/ 2018-07-04T14:12:45+00:00 https://www.pharmaceutical-business-review.com/news/bc488wyeth_files_for_australian_approval_of_constipation/ 2018-07-04T14:12:45+00:00 https://www.pharmaceutical-business-review.com/news/4a49ecompugen_strikes_drug_deal_with/ 2018-07-04T14:12:46+00:00 https://www.pharmaceutical-business-review.com/news/694aeadvanced_life_sciences_metastatic_melanoma_drug_granted_orphan_s/ 2018-07-04T14:12:46+00:00 https://www.pharmaceutical-business-review.com/news/724b0vical_begins_trial_of_dna_vaccine_for_bir/ 2018-07-04T14:12:46+00:00 https://www.pharmaceutical-business-review.com/news/a34bfmedco_acquires_polymedica_for_15_bi/ 2018-07-04T14:12:46+00:00 https://www.pharmaceutical-business-review.com/news/a14accuragen_and_topotarget_start_leukemia_treatment_/ 2018-07-04T14:12:47+00:00 https://www.pharmaceutical-business-review.com/news/ee488protalix_begins_pivotal_gaucher_disease_/ 2018-07-04T14:12:48+00:00 https://www.pharmaceutical-business-review.com/news/e548ctorreypines_initiates_phase_i_trial_of_pain_com/ 2018-07-04T14:12:48+00:00 https://www.pharmaceutical-business-review.com/news/e24a8indevus_files_nda_for_testosterone/ 2018-07-04T14:12:48+00:00 https://www.pharmaceutical-business-review.com/news/214b2drug_royalty_buys_pegintron_royalty_for_925_mi/ 2018-07-04T14:12:48+00:00 https://www.pharmaceutical-business-review.com/news/ec4b5kinemed_to_work_with_merck_kgaa_on_preclinical_/ 2018-07-04T14:12:48+00:00 https://www.pharmaceutical-business-review.com/news/0a4b3pfizer_and_bristolmyers_partner_for_metabolic_disorders_pr/ 2018-07-04T14:12:49+00:00 https://www.pharmaceutical-business-review.com/news/184a0fda_declines_approval_of_idm_pharmas_osteosarcoma/ 2018-07-04T14:12:49+00:00 https://www.pharmaceutical-business-review.com/news/e3484depomed_chairman_ceo_re/ 2018-07-04T14:12:49+00:00 https://www.pharmaceutical-business-review.com/news/ca481heritage_ipca_enter_agreement_for_generic_pharma_pro/ 2018-07-04T14:12:49+00:00 https://www.pharmaceutical-business-review.com/news/3f483akela_pharma_enrolls_first_patient_in_asthma_/ 2018-07-04T14:12:50+00:00 https://www.pharmaceutical-business-review.com/news/9149bdiamyd_plans_cancer_pain_drug_clinical_t/ 2018-07-04T14:12:51+00:00 https://www.pharmaceutical-business-review.com/news/624b1eu_approves_novartis_blood_pressure/ 2018-07-04T14:12:51+00:00 https://www.pharmaceutical-business-review.com/news/93485neurochem_reports_on_alzheimers_disease_drug_trial_re/ 2018-07-04T14:12:51+00:00 https://www.pharmaceutical-business-review.com/news/35484bayers_nexavar_found_to_improve_sur/ 2018-07-04T14:12:51+00:00 https://www.pharmaceutical-business-review.com/news/e74begenentech_refiles_for_additional_avastin_indic/ 2018-07-04T14:12:51+00:00 https://www.pharmaceutical-business-review.com/news/964bcmedimmune_licenses_vaccine_technology_to_nov/ 2018-07-04T14:12:52+00:00 https://www.pharmaceutical-business-review.com/news/96498gene_logic_agrees_to_develop_merck_kgaas_dropped_/ 2018-07-04T14:12:52+00:00 https://www.pharmaceutical-business-review.com/news/654accephalon_buys_muscle_relaxant/ 2018-07-04T14:12:52+00:00 https://www.pharmaceutical-business-review.com/news/a8496atherogenics_starts_pivotal_diabetes_/ 2018-07-04T14:12:52+00:00 https://www.pharmaceutical-business-review.com/news/6f4a3collagenex_drug_meets_trial/ 2018-07-04T14:12:54+00:00 https://www.pharmaceutical-business-review.com/news/0c48bregeneron_begins_pivotal_cancer_drug_t/ 2018-07-04T14:12:54+00:00 https://www.pharmaceutical-business-review.com/news/b54a9astrazeneca_starts_midstage_schizophrenia_drug_/ 2018-07-04T14:12:55+00:00 https://www.pharmaceutical-business-review.com/news/d04aemedimmune_rsv_drug_meets_trial_/ 2018-07-04T14:12:55+00:00 https://www.pharmaceutical-business-review.com/news/03491gpc_biotech_sued_over_satraplatin_/ 2018-07-04T14:12:55+00:00 https://www.pharmaceutical-business-review.com/news/8e4abnew_cancer_drugs_linked_to_side_effect_i/ 2018-07-04T14:12:55+00:00 https://www.pharmaceutical-business-review.com/news/c74a9gpc_biotech_cuts_15_of_/ 2018-07-04T14:12:55+00:00 https://www.pharmaceutical-business-review.com/news/a04a9gsk_accelerates_review_of_exelixiss_cancer/ 2018-07-04T14:12:56+00:00 https://www.pharmaceutical-business-review.com/news/044bcthallion_completes_extension_phase_of_cancer_/ 2018-07-04T14:12:56+00:00 https://www.pharmaceutical-business-review.com/news/234b9alfacell_reports_promising_results_for_cancer/ 2018-07-04T14:12:56+00:00 https://www.pharmaceutical-business-review.com/news/234b4research_breakthrough_for_huntingtons_pat/ 2018-07-04T14:12:57+00:00 https://www.pharmaceutical-business-review.com/news/0c4a5midstage_hiv_vaccine_trial_shows_encouraging_re/ 2018-07-04T14:12:57+00:00 https://www.pharmaceutical-business-review.com/news/dd4b9risperdal_approved_for_two_more_indications_/ 2018-07-04T14:12:58+00:00 https://www.pharmaceutical-business-review.com/news/f94aemarqibo_receives_fast_track_status_fro/ 2018-07-04T14:12:58+00:00 https://www.pharmaceutical-business-review.com/news/494acnice_recommends_mabthera_for_rheumatoid_arth/ 2018-07-04T14:12:58+00:00 https://www.pharmaceutical-business-review.com/news/9a4a5daiichi_sankyo_and_forest_laboratories_sign_copromotion_agre/ 2018-07-04T14:12:58+00:00 https://www.pharmaceutical-business-review.com/news/6f4a5alpharma_acquires_license_for_pain_patch_from_institut_biochi/ 2018-07-04T14:12:58+00:00 https://www.pharmaceutical-business-review.com/news/6a4b4eli_lilly_reports_encouraging_cymbalta_re/ 2018-07-04T14:12:59+00:00 https://www.pharmaceutical-business-review.com/news/814b7ym_biosciences_cancer_drug_cleared_for_extra_europe_t/ 2018-07-04T14:12:59+00:00 https://www.pharmaceutical-business-review.com/news/3a485targeted_genetics_reports_positive_hiv_vaccine/ 2018-07-04T14:12:59+00:00 https://www.pharmaceutical-business-review.com/news/394b1enzon_sells_25_royalty_in_hepatitis_c_drug_pegi/ 2018-07-04T14:13:00+00:00 https://www.pharmaceutical-business-review.com/news/2f4bapericor_scheringplough_close_acadesine_licensing_agre/ 2018-07-04T14:13:00+00:00 https://www.pharmaceutical-business-review.com/news/4c483biopartners_submits_ms_treatment_to_the/ 2018-07-04T14:13:01+00:00 https://www.pharmaceutical-business-review.com/news/b7486fda_requests_additional_data_on_solvay_pancreatic/ 2018-07-04T14:13:01+00:00 https://www.pharmaceutical-business-review.com/news/a74b7fda_approves_reclast_for_postmenopausal_osteoporosis_trea/ 2018-07-04T14:13:01+00:00 https://www.pharmaceutical-business-review.com/news/644b1edap_combines_hifu_and_chemotherapy_for_prostate_cancer_/ 2018-07-04T14:13:01+00:00 https://www.pharmaceutical-business-review.com/news/21497soliris_reduces_blood_clots_in_pnh_patients_by_92_study_/ 2018-07-04T14:13:01+00:00 https://www.pharmaceutical-business-review.com/news/7e4a3tikvah_receives_orphan_drug_status_for_muscle_wasting_th/ 2018-07-04T14:13:02+00:00 https://www.pharmaceutical-business-review.com/news/8e489pharmion_and_methylgene_expand_cancer_research_agre/ 2018-07-04T14:13:02+00:00 https://www.pharmaceutical-business-review.com/news/924beepicept_reports_on_cancer_compound_trial_develop/ 2018-07-04T14:13:02+00:00 https://www.pharmaceutical-business-review.com/news/6c48asantarus_receives_5_million_milestone_from_scheringp/ 2018-07-04T14:13:03+00:00 https://www.pharmaceutical-business-review.com/news/e14actysabri_shows_improvement_in_quality_of/ 2018-07-04T14:13:03+00:00 https://www.pharmaceutical-business-review.com/news/164badendreon_reports_positive_results_for_breast_cancer_trea/ 2018-07-04T14:13:04+00:00 https://www.pharmaceutical-business-review.com/news/3d4becangenes_government_vaccine_contract_exp/ 2018-07-04T14:13:04+00:00 https://www.pharmaceutical-business-review.com/news/ae499myriad_genetics_initiates_phase_ii_trial_of_azixa_in_lung_c/ 2018-07-04T14:13:04+00:00 https://www.pharmaceutical-business-review.com/news/82480delsite_begins_toxicology_studies_of_its_bird_flu_va/ 2018-07-04T14:13:04+00:00 https://www.pharmaceutical-business-review.com/news/29491romark_initiates_trial_of_alinia_for_hepati/ 2018-07-04T14:13:05+00:00 https://www.pharmaceutical-business-review.com/news/f9497millipore_and_novo_nordisk_expand_insulin_supply/ 2018-07-04T14:13:05+00:00 https://www.pharmaceutical-business-review.com/news/15490adventrx_gets_fda_fast_track_designation_for_cancer_inje/ 2018-07-04T14:13:05+00:00 https://www.pharmaceutical-business-review.com/news/c94a8cell_therapeutics_to_acquire_lymphoma_drug_from_biogen/ 2018-07-04T14:13:05+00:00 https://www.pharmaceutical-business-review.com/news/404a7parion_and_gilead_strike_deal_to_advance_pulmonary_disease_/ 2018-07-04T14:13:07+00:00 https://www.pharmaceutical-business-review.com/news/7a4a4millennium_initiates_trial_for_multiple_myeloma_trea/ 2018-07-04T14:13:07+00:00 https://www.pharmaceutical-business-review.com/news/8d4aacephalon_reports_positive_phase_iii_fentora_re/ 2018-07-04T14:13:08+00:00 https://www.pharmaceutical-business-review.com/news/954beendo_and_vernalis_provide_update_on_/ 2018-07-04T14:13:08+00:00 https://www.pharmaceutical-business-review.com/news/e44b1allos_therapeutics_to_test_lymphoma/ 2018-07-04T14:13:08+00:00 https://www.pharmaceutical-business-review.com/news/3e4b0king_pharmaceuticals_now_distributing_bicilli/ 2018-07-04T14:13:08+00:00 https://www.pharmaceutical-business-review.com/news/f14bcym_biosciences_reports_progress_of_brain_cancer_/ 2018-07-04T14:13:08+00:00 https://www.pharmaceutical-business-review.com/news/3a4b2ekr_acquires_rights_to_de/ 2018-07-04T14:13:09+00:00 https://www.pharmaceutical-business-review.com/news/f7481emea_recommends_orphan_drug_designation_for_progen_/ 2018-07-04T14:13:09+00:00 https://www.pharmaceutical-business-review.com/news/e24aegsk_diabetes_drug_to_carry_black_box_wa/ 2018-07-04T14:13:09+00:00 https://www.pharmaceutical-business-review.com/news/eb4bfcombinatorx_begins_phase_iia_diabetes_treatment_/ 2018-07-04T14:13:14+00:00 https://www.pharmaceutical-business-review.com/news/854aecytokinetics_gsk_begin_phase_i_trial_for_tumor_trea/ 2018-07-04T14:13:14+00:00 https://www.pharmaceutical-business-review.com/news/c7497celsci_secures_manufacturing_facility_for_multikine_cancer/ 2018-07-04T14:13:14+00:00 https://www.pharmaceutical-business-review.com/news/08491gsks_rotarix_drug_application_gets_fda_r/ 2018-07-04T14:13:14+00:00 https://www.pharmaceutical-business-review.com/news/714bbneuraxon_reports_positive_phase_i_data_for_migraine_trea/ 2018-07-04T14:13:15+00:00 https://www.pharmaceutical-business-review.com/news/3048fbiogen_idec_reports_encouraging_study_results_for_ad/ 2018-07-04T14:13:15+00:00 https://www.pharmaceutical-business-review.com/news/84489argentis_signs_license_agreement_for_scleroderma_trea/ 2018-07-04T14:13:15+00:00 https://www.pharmaceutical-business-review.com/news/3f49abrainstorm_on_the_road_to_clinical_studies_in_parkinsons_di/ 2018-07-04T14:13:15+00:00 https://www.pharmaceutical-business-review.com/news/714bdsinovac_begins_vaccinating_volunteers_in_pandemic_flu_/ 2018-07-04T14:13:15+00:00 https://www.pharmaceutical-business-review.com/news/df48ejacobs_lands_contract_from_pfizer_for_new_biotech_manufacturing_c/ 2018-07-04T14:13:15+00:00 https://www.pharmaceutical-business-review.com/news/4e49cec_grants_chelsea_therapeuticss_droxidopa_two_orphan_designa/ 2018-07-04T14:13:17+00:00 https://www.pharmaceutical-business-review.com/news/ab4b0icagen_forms_alliance_with_p/ 2018-07-04T14:13:17+00:00 https://www.pharmaceutical-business-review.com/news/9c4bacv_therapeutics_launches_1000mg_ranexa_t/ 2018-07-04T14:13:17+00:00 https://www.pharmaceutical-business-review.com/news/604adepix_achieves_discovery_milestone_in_collaboration_wit/ 2018-07-04T14:13:17+00:00 https://www.pharmaceutical-business-review.com/news/a44b6sanofi_pasteur_begins_influenza_vaccine_shi/ 2018-07-04T14:13:18+00:00 https://www.pharmaceutical-business-review.com/news/a3488arius_announces_issuance_of_two_us_pa/ 2018-07-04T14:13:18+00:00 https://www.pharmaceutical-business-review.com/news/14480bedford_laboratories_to_begin_shipping_pentostatin_for_inje/ 2018-07-04T14:13:18+00:00 https://www.pharmaceutical-business-review.com/news/2c4bbregeneron_gets_20_million_milestone_payment_for_phase_iii_/ 2018-07-04T14:13:18+00:00 https://www.pharmaceutical-business-review.com/news/f04bfcaraco_granted_tentative_fda_approval_for_generic_pr/ 2018-07-04T14:13:18+00:00 https://www.pharmaceutical-business-review.com/news/394bfactavis_receives_approval_for_generic_inderal_cap/ 2018-07-04T14:13:19+00:00 https://www.pharmaceutical-business-review.com/news/f64b3researchers_recommend_using_coxibs_and_nsaids_to_treat_osteoarth/ 2018-07-04T14:13:20+00:00 https://www.pharmaceutical-business-review.com/news/e4495new_treatment_for_counteracting_cocaineinduced_cardio_sym/ 2018-07-04T14:13:20+00:00 https://www.pharmaceutical-business-review.com/news/ea49fnew_study_indicates_potential_of_phenoxodiol_as_neuropathy_trea/ 2018-07-04T14:13:20+00:00 https://www.pharmaceutical-business-review.com/news/92493fda_rejects_wyeths_schizophrenia/ 2018-07-04T14:13:21+00:00 https://www.pharmaceutical-business-review.com/news/d0493genta_launches_genasense_named_patientcompassionate_use_pr/ 2018-07-04T14:13:21+00:00 https://www.pharmaceutical-business-review.com/news/1d4a3biomarin_reports_positive_phase_iii_kuvan_re/ 2018-07-04T14:13:21+00:00 https://www.pharmaceutical-business-review.com/news/bd4a7biomarin_submits_naglazyme_bla_to_japanese_health_min/ 2018-07-04T14:13:21+00:00 https://www.pharmaceutical-business-review.com/news/3a48bfda_approves_lifecycle_pharmas_new_fenofibrate_formul/ 2018-07-04T14:13:21+00:00 https://www.pharmaceutical-business-review.com/news/4648bunigene_inlicenses_potential_therapies_from_university_of_l/ 2018-07-04T14:13:22+00:00 https://www.pharmaceutical-business-review.com/news/de482fda_approves_abraxiss_cefotetan_disodium_for_inje/ 2018-07-04T14:13:22+00:00 https://www.pharmaceutical-business-review.com/news/2e4b6mylan_gets_fda_approval_for_generic_blood_pressure_cap/ 2018-07-04T14:13:23+00:00 https://www.pharmaceutical-business-review.com/news/314b6novartis_granted_market_exclusivity_for_d/ 2018-07-04T14:13:23+00:00 https://www.pharmaceutical-business-review.com/news/e2486pb_biosciences_and_dong_wha_to_develop_zaboflo/ 2018-07-04T14:13:23+00:00 https://www.pharmaceutical-business-review.com/news/6b4abuk_court_backs_alzheimers_drug_restric/ 2018-07-04T14:13:24+00:00 https://www.pharmaceutical-business-review.com/news/314a7alnylam_lands_386_million_federal_government_con/ 2018-07-04T14:13:24+00:00 https://www.pharmaceutical-business-review.com/news/37498fda_approves_ind_for_phase_ii_studies_of/ 2018-07-04T14:13:24+00:00 https://www.pharmaceutical-business-review.com/news/b3487taigen_completes_patient_recruitment_for_phase_ii_trial_of_nemono/ 2018-07-04T14:13:24+00:00 https://www.pharmaceutical-business-review.com/news/4d498aveo_completes_discovery_agreement_for_novel_cancer_/ 2018-07-04T14:13:24+00:00 https://www.pharmaceutical-business-review.com/news/e34b0sirtris_initiates_phase_ib_clinical_trial_of_melas/ 2018-07-04T14:13:25+00:00 https://www.pharmaceutical-business-review.com/news/d14bfshareholders_approve_peptechevogenix_m/ 2018-07-04T14:13:25+00:00 https://www.pharmaceutical-business-review.com/news/db4acfda_clears_spectrums_new_drug_applic/ 2018-07-04T14:13:26+00:00 https://www.pharmaceutical-business-review.com/news/494b4rhein_minapharm_licenses_elafin_from_p/ 2018-07-04T14:13:26+00:00 https://www.pharmaceutical-business-review.com/news/c849adov_pharmaceutical_reports_successful_phase_ib_re/ 2018-07-04T14:13:26+00:00 https://www.pharmaceutical-business-review.com/news/5f4b4astrazeneca_stomach_drugs_pose_no_heart_risk_fda_/ 2018-07-04T14:13:27+00:00 https://www.pharmaceutical-business-review.com/news/2f4b6no_evidence_statins_protect_against_prostate_cancer_study_/ 2018-07-04T14:13:27+00:00 https://www.pharmaceutical-business-review.com/news/0448cnew_research_aims_to_stop_cancer_cells_reading_their_ow/ 2018-07-04T14:13:27+00:00 https://www.pharmaceutical-business-review.com/news/7b4b7tercica_receives_eu_marketing_approval_for_inc/ 2018-07-04T14:13:27+00:00 https://www.pharmaceutical-business-review.com/news/71498paladin_expands_distribution_agreement_with_shir/ 2018-07-04T14:13:27+00:00 https://www.pharmaceutical-business-review.com/news/124adbiovail_posts_disappointing_q2_re/ 2018-07-04T14:13:28+00:00 https://www.pharmaceutical-business-review.com/news/3f4acabraxis_bioscience_launches_generic_adria/ 2018-07-04T14:13:28+00:00 https://www.pharmaceutical-business-review.com/news/2e4adstem_cell_transplantation_boosts_survival_of_amyloidosis_pat/ 2018-07-04T14:13:29+00:00 https://www.pharmaceutical-business-review.com/news/3a489fda_rejects_higher_dose_of_gsks_a/ 2018-07-04T14:13:29+00:00 https://www.pharmaceutical-business-review.com/news/c9495chemotherapy_with_avastin_increases_blood_clot_risk_study_/ 2018-07-04T14:13:29+00:00 https://www.pharmaceutical-business-review.com/news/834bccourt_denies_terminally_ill_right_to_unapproved_/ 2018-07-04T14:13:29+00:00 https://www.pharmaceutical-business-review.com/news/23495fda_requests_additional_trial_data_for_skyepharma_asthma/ 2018-07-04T14:13:30+00:00 https://www.pharmaceutical-business-review.com/news/da4adphosphagenics_reports_successful_phase_ib_/ 2018-07-04T14:13:30+00:00 https://www.pharmaceutical-business-review.com/news/9448dneuromed_and_merck_drop_pain_d/ 2018-07-04T14:13:30+00:00 https://www.pharmaceutical-business-review.com/news/a84bebiomira_merck_amend_stimuvax_agre/ 2018-07-04T14:13:30+00:00 https://www.pharmaceutical-business-review.com/news/c64b1meridian_bioscience_to_produce_experimental_vac/ 2018-07-04T14:13:31+00:00 https://www.pharmaceutical-business-review.com/news/0449bfda_approves_larger_version_of_oxytocin_inje/ 2018-07-04T14:13:31+00:00 https://www.pharmaceutical-business-review.com/news/be4abarchemix_and_isis_to_collaborate_on_aptamer_techn/ 2018-07-04T14:13:32+00:00 https://www.pharmaceutical-business-review.com/news/5848bgsk_allows_manufacture_of_generic_drug_for_rwandan_hiv_pat/ 2018-07-04T14:13:32+00:00 https://www.pharmaceutical-business-review.com/news/f94befermavir_shingles_drug_shows_potential_in_animal_t/ 2018-07-04T14:13:33+00:00 https://www.pharmaceutical-business-review.com/news/f8495fda_accepts_orencia_license_applic/ 2018-07-04T14:13:33+00:00 https://www.pharmaceutical-business-review.com/news/0648adynavax_secures_3_million_flu_vaccine_/ 2018-07-04T14:13:33+00:00 https://www.pharmaceutical-business-review.com/news/b1481roche_hiv_drug_banned_/ 2018-07-04T14:13:33+00:00 https://www.pharmaceutical-business-review.com/news/7f49fbiovitrum_to_copromote_hemophilia_treatment_with_/ 2018-07-04T14:13:33+00:00 https://www.pharmaceutical-business-review.com/news/dc482epix_reports_positive_topline_results_for_copd/ 2018-07-04T14:13:33+00:00 https://www.pharmaceutical-business-review.com/news/804a7bayer_q2_profit_u/ 2018-07-04T14:13:34+00:00 https://www.pharmaceutical-business-review.com/news/d44bfavi_drops_hepatitis_c_trial_to_focus_on_ne/ 2018-07-04T14:13:34+00:00 https://www.pharmaceutical-business-review.com/news/814a4galapagos_expands_alliance_with_astraz/ 2018-07-04T14:13:35+00:00 https://www.pharmaceutical-business-review.com/news/f148fgammacan_receives_fda_orphan_drug_designation_for_vi/ 2018-07-04T14:13:35+00:00 https://www.pharmaceutical-business-review.com/news/394b6pfizer_plans_to_triple_phase_iii_drug_port/ 2018-07-04T14:13:36+00:00 https://www.pharmaceutical-business-review.com/news/0e49ckinemed_and_merck_collaborate_on_atherosclerosis_res/ 2018-07-04T14:13:36+00:00 https://www.pharmaceutical-business-review.com/news/cd491medicines_company_submits_angiomax_application_t/ 2018-07-04T14:13:36+00:00 https://www.pharmaceutical-business-review.com/news/7b4b0pfizers_selzentry_treatment_for_hiv_approved_b/ 2018-07-04T14:13:36+00:00 https://www.pharmaceutical-business-review.com/news/dd4bcprana_phase_iia_alzheimers_disease_trial_cont/ 2018-07-04T14:13:36+00:00 https://www.pharmaceutical-business-review.com/news/7a4a8publix_launches_free_prescription_drug_pr/ 2018-07-04T14:13:37+00:00 https://www.pharmaceutical-business-review.com/news/0b4bcbayer_and_nektar_form_antibiotic_agre/ 2018-07-04T14:13:37+00:00 https://www.pharmaceutical-business-review.com/news/a3482fda_approves_extendedrelease_san/ 2018-07-04T14:13:37+00:00 https://www.pharmaceutical-business-review.com/news/434bbxoma_appoints_steven_engle_president_ceo_and_dir/ 2018-07-04T14:13:40+00:00 https://www.pharmaceutical-business-review.com/news/1849atorreypines_completes_patient_enrollment_in_midstage_/ 2018-07-04T14:13:40+00:00 https://www.pharmaceutical-business-review.com/news/c74afavanir_completes_sale_of_fazaclo_to/ 2018-07-04T14:13:40+00:00 https://www.pharmaceutical-business-review.com/news/164bdleo_pharma_starts_midstage_anticoagulant_/ 2018-07-04T14:13:40+00:00 https://www.pharmaceutical-business-review.com/news/da490via_pharmaceuticals_granted_patent_rights_for_inflammation_com/ 2018-07-04T14:13:41+00:00 https://www.pharmaceutical-business-review.com/news/9e4aenovartis_cancer_drug_patent_rejected_in_indian_/ 2018-07-04T14:13:41+00:00 https://www.pharmaceutical-business-review.com/news/3d4aagsk_receives_new_us_order_for_avian_flu_va/ 2018-07-04T14:13:41+00:00 https://www.pharmaceutical-business-review.com/news/2249epfizer_files_petition_against_government_r/ 2018-07-04T14:13:41+00:00 https://www.pharmaceutical-business-review.com/news/7b487pfizer_begins_clinical_trials_for_gi_disorder/ 2018-07-04T14:13:41+00:00 https://www.pharmaceutical-business-review.com/news/02483breckenridge_pharmaceutics_enter_hrt_product_agre/ 2018-07-04T14:13:42+00:00 https://www.pharmaceutical-business-review.com/news/4d4b8intellect_and_mrct_collaborate_on_alzheimers/ 2018-07-04T14:13:44+00:00 https://www.pharmaceutical-business-review.com/news/cc493antisoma_starts_phase_ii_leukemia_/ 2018-07-04T14:13:44+00:00 https://www.pharmaceutical-business-review.com/news/f04aamolecular_switch_discovery_could_lead_to_new_neurological_ther/ 2018-07-04T14:13:44+00:00 https://www.pharmaceutical-business-review.com/news/62486par_pharmaceutical_begins_shipment_of_generic_topr/ 2018-07-04T14:13:44+00:00 https://www.pharmaceutical-business-review.com/news/b14b1innovive_reaches_agreement_with_fda_for_leukemia_drug_/ 2018-07-04T14:13:44+00:00 https://www.pharmaceutical-business-review.com/news/7348farray_biopharma_advances_breast_cancer/ 2018-07-04T14:13:45+00:00 https://www.pharmaceutical-business-review.com/news/f84actekmira_partner_begins_phase_ii_clinical_trial_for_ma/ 2018-07-04T14:13:45+00:00 https://www.pharmaceutical-business-review.com/news/1e4acquark_says_animal_trial_results_for_sirna_drug_are_encour/ 2018-07-04T14:13:45+00:00 https://www.pharmaceutical-business-review.com/news/fd49efda_clears_isotechnikas_transplant_drug_for_longter/ 2018-07-04T14:13:45+00:00 https://www.pharmaceutical-business-review.com/news/da4a0gtc_and_lfb_to_develop_followon_ritu/ 2018-07-04T14:13:45+00:00 https://www.pharmaceutical-business-review.com/news/814a8peregrine_doses_first_patient_in_brain_cancer_tr/ 2018-07-04T14:13:48+00:00 https://www.pharmaceutical-business-review.com/news/32498fda_blocks_trexima_approval_/ 2018-07-04T14:13:48+00:00 https://www.pharmaceutical-business-review.com/news/50490european_marketing_approval_for_scheringplough_hay_fever/ 2018-07-04T14:13:48+00:00 https://www.pharmaceutical-business-review.com/news/5d4a7pharmion_reports_improved_survival_in_mds_for_v/ 2018-07-04T14:13:48+00:00 https://www.pharmaceutical-business-review.com/news/7b4a0nice_recommends_against_orencia_o/ 2018-07-04T14:13:49+00:00 https://www.pharmaceutical-business-review.com/news/3d4a2barr_president_and_coo_re/ 2018-07-04T14:13:49+00:00 https://www.pharmaceutical-business-review.com/news/3d4a6nuvelo_axes_onethird_of_work/ 2018-07-04T14:13:49+00:00 https://www.pharmaceutical-business-review.com/news/8a4b1jj_to_axe_4_of_global_work/ 2018-07-04T14:13:49+00:00 https://www.pharmaceutical-business-review.com/news/8f49aanadys_axes_hepatitis_drug_development_cuts_work/ 2018-07-04T14:13:50+00:00 https://www.pharmaceutical-business-review.com/news/5c4b9merck_ends_research_agreement_with_methy/ 2018-07-04T14:13:50+00:00 https://www.pharmaceutical-business-review.com/news/2a4b8enzon_starts_enrollment_for_phase_i_cancer_drug_/ 2018-07-04T14:13:52+00:00 https://www.pharmaceutical-business-review.com/news/eb49dcanopus_says_flu_candidate_superior_to_tamiflu_in_preclinical_st/ 2018-07-04T14:13:53+00:00 https://www.pharmaceutical-business-review.com/news/404acmedimmune_begins_asthma_drug_/ 2018-07-04T14:13:53+00:00 https://www.pharmaceutical-business-review.com/news/3f49bastions_lupus_drug_to_receive_orphan_s/ 2018-07-04T14:13:53+00:00 https://www.pharmaceutical-business-review.com/news/7e48ccubicin_receives_approvals_in_south_korea_and_t/ 2018-07-04T14:13:53+00:00 https://www.pharmaceutical-business-review.com/news/a74b9orexo_and_prostraken_fo/ 2018-07-04T14:13:53+00:00 https://www.pharmaceutical-business-review.com/news/694a7iomais_vaccine_shows_encouraging_re/ 2018-07-04T14:13:54+00:00 https://www.pharmaceutical-business-review.com/news/a5489abraxis_buys_manufacturing_facility_from_w/ 2018-07-04T14:13:54+00:00 https://www.pharmaceutical-business-review.com/news/454b3valeant_starts_pivotal_epilepsy_drug_/ 2018-07-04T14:13:54+00:00 https://www.pharmaceutical-business-review.com/news/4d4bfbms_and_scheringplough_sued_over_t/ 2018-07-04T14:13:54+00:00 https://www.pharmaceutical-business-review.com/news/504bdadvisory_panel_votes_in_favor_of_tysabri_for_cr/ 2018-07-04T14:13:56+00:00 https://www.pharmaceutical-business-review.com/news/5d495lev_pharmaceuticals_seeks_regulatory_approval_for_angioedema/ 2018-07-04T14:13:56+00:00 https://www.pharmaceutical-business-review.com/news/a34b7ym_biosciences_enrolls_first_patients_in_colorectal_cancer_/ 2018-07-04T14:13:56+00:00 https://www.pharmaceutical-business-review.com/news/5c492lux_biosciences_eye_drug_set_to_receive_orphan_design/ 2018-07-04T14:13:57+00:00 https://www.pharmaceutical-business-review.com/news/504a2accentia_files_preliminary_ind_for_ms/ 2018-07-04T14:13:57+00:00 https://www.pharmaceutical-business-review.com/news/c84a1immunogen_set_to_receive_5_million_milestone_from_gene/ 2018-07-04T14:13:57+00:00 https://www.pharmaceutical-business-review.com/news/624b1lexicons_cognitive_disorders_drug_meets_trial_/ 2018-07-04T14:13:57+00:00 https://www.pharmaceutical-business-review.com/news/bf494crucell_signs_license_agreement_with_/ 2018-07-04T14:13:57+00:00 https://www.pharmaceutical-business-review.com/news/73494silence_and_quark_expand_agre/ 2018-07-04T14:13:58+00:00 https://www.pharmaceutical-business-review.com/news/04495fda_panel_votes_to_keep_avandia_on_the_mar/ 2018-07-04T14:13:58+00:00 https://www.pharmaceutical-business-review.com/news/17491sernova_files_patent_application_for_diabetes_cell_th/ 2018-07-04T14:13:59+00:00 https://www.pharmaceutical-business-review.com/news/7249davant_commences_phase_ii_trial_of_typhoid_fever_va/ 2018-07-04T14:13:59+00:00 https://www.pharmaceutical-business-review.com/news/584b9fda_sued_over_prostate_cancer_va/ 2018-07-04T14:13:59+00:00 https://www.pharmaceutical-business-review.com/news/a14b3gpc_biotech_withdraws_satraplatin_from_fast_/ 2018-07-04T14:14:00+00:00 https://www.pharmaceutical-business-review.com/news/f4492studies_point_to_new_genes_associated_with_ms/ 2018-07-04T14:14:00+00:00 https://www.pharmaceutical-business-review.com/news/604a3gene_logic_drug_candidate_shows_positive_in_vivo_test_re/ 2018-07-04T14:14:00+00:00 https://www.pharmaceutical-business-review.com/news/21481medivation_begins_phase_ii_dimebon_/ 2018-07-04T14:14:00+00:00 https://www.pharmaceutical-business-review.com/news/324a1new_tb_vaccine_being_developed_in_south_afr/ 2018-07-04T14:14:01+00:00 https://www.pharmaceutical-business-review.com/news/ea498fda_to_allow_zelnorm_under_restricted_a/ 2018-07-04T14:14:01+00:00 https://www.pharmaceutical-business-review.com/news/7848dbristolmyers_imclone_expand_erbitux_development_pr/ 2018-07-04T14:14:01+00:00 https://www.pharmaceutical-business-review.com/news/a24b7regulatory_concern_for_tysabri_in_cr/ 2018-07-04T14:14:03+00:00 https://www.pharmaceutical-business-review.com/news/da48ecalcitonin_shows_promise_as_preventative_therapy_/ 2018-07-04T14:14:04+00:00 https://www.pharmaceutical-business-review.com/news/0a4b2uk_doctors_may_reject_lucentis_in_favor_of_unlicensed_drug__r/ 2018-07-04T14:14:04+00:00 https://www.pharmaceutical-business-review.com/news/74480shires_new_adhd_medication_now_avai/ 2018-07-04T14:14:04+00:00 https://www.pharmaceutical-business-review.com/news/dc492spanish_court_upholds_pfizers_lipitor_p/ 2018-07-04T14:14:04+00:00 https://www.pharmaceutical-business-review.com/news/774a2genstar_to_buy_pra_internat/ 2018-07-04T14:14:04+00:00 https://www.pharmaceutical-business-review.com/news/464acpropharmaceuticals_begins_patient_dosing_for_biliary_cancer_/ 2018-07-04T14:14:05+00:00 https://www.pharmaceutical-business-review.com/news/814a1lexiva_and_reyataz_show_similar_efficacy_in_new_/ 2018-07-04T14:14:05+00:00 https://www.pharmaceutical-business-review.com/news/a8482cell_therapeutics_acquires_smi_gains_rights_to_cancer_killing_/ 2018-07-04T14:14:05+00:00 https://www.pharmaceutical-business-review.com/news/52482roches_actemra_drug_filing_planned_for_yea/ 2018-07-04T14:14:05+00:00 https://www.pharmaceutical-business-review.com/news/a34a8wyeths_pristiq_hit_by_fda_safety_con/ 2018-07-04T14:14:08+00:00 https://www.pharmaceutical-business-review.com/news/bd48ebiomss_multiple_sclerosis_trial_gets_positive_r/ 2018-07-04T14:14:08+00:00 https://www.pharmaceutical-business-review.com/news/d1485orexigen_obesity_drug_candidate_successful_in_phase_/ 2018-07-04T14:14:08+00:00 https://www.pharmaceutical-business-review.com/news/5949dicagen_files_ind_for_epilepsy_treatment_com/ 2018-07-04T14:14:08+00:00 https://www.pharmaceutical-business-review.com/news/8a4bfscheringplough_hiv_product_shows_promise_in_pha/ 2018-07-04T14:14:09+00:00 https://www.pharmaceutical-business-review.com/news/4b496entremed_commences_leukemia_trial_in_c/ 2018-07-04T14:14:09+00:00 https://www.pharmaceutical-business-review.com/news/4b48dbiocryst_begins_phase_ii_trial_for_influenza/ 2018-07-04T14:14:09+00:00 https://www.pharmaceutical-business-review.com/news/4b499xencor_drug_shows_promise_in_preclinical_/ 2018-07-04T14:14:09+00:00 https://www.pharmaceutical-business-review.com/news/1b48bpluristems_plx_cells_show_promise_in_treating_limb_isc/ 2018-07-04T14:14:09+00:00 https://www.pharmaceutical-business-review.com/news/a2493advanced_magnetics_reports_positive_results_for_chronic_kidney_disease_tr/ 2018-07-04T14:14:10+00:00 https://www.pharmaceutical-business-review.com/news/60489medimmune_reports_asthma_therapy_is_well_tole/ 2018-07-04T14:14:11+00:00 https://www.pharmaceutical-business-review.com/news/c8485targacept_initiates_phase_iib_development_of_alzheimers/ 2018-07-04T14:14:12+00:00 https://www.pharmaceutical-business-review.com/news/cb4a7neurochems_alzheimers_drug_given_fast_track_s/ 2018-07-04T14:14:12+00:00 https://www.pharmaceutical-business-review.com/news/c04b8inovio_to_collaborate_with_research_centers_on_dna_va/ 2018-07-04T14:14:12+00:00 https://www.pharmaceutical-business-review.com/news/4a48dincyte_reports_positive_midstage_hiv_drug_re/ 2018-07-04T14:14:12+00:00 https://www.pharmaceutical-business-review.com/news/454b8eli_lilly_reports_first_half_revenue_increase_raises_gui/ 2018-07-04T14:14:13+00:00 https://www.pharmaceutical-business-review.com/news/c44benventa_reports_positive_cervical_cancer_treatment_re/ 2018-07-04T14:14:13+00:00 https://www.pharmaceutical-business-review.com/news/59488isotechnika_completes_recruitment_for_pivotal_psoriasis_/ 2018-07-04T14:14:13+00:00 https://www.pharmaceutical-business-review.com/news/a1487gilead_study_confirms_atripla_eff/ 2018-07-04T14:14:13+00:00 https://www.pharmaceutical-business-review.com/news/064badepomed_and_watson_ink_promotion_agre/ 2018-07-04T14:14:13+00:00 https://www.pharmaceutical-business-review.com/news/d1495qiagen_moves_forward_with_digene_m/ 2018-07-04T14:14:16+00:00 https://www.pharmaceutical-business-review.com/news/87485menopause_drug_to_be_withdrawn_in_e/ 2018-07-04T14:14:16+00:00 https://www.pharmaceutical-business-review.com/news/2a480adventrx_reports_promising_hiv_drug/ 2018-07-04T14:14:16+00:00 https://www.pharmaceutical-business-review.com/news/45494fda_to_review_acne_drug_label_c/ 2018-07-04T14:14:16+00:00 https://www.pharmaceutical-business-review.com/news/474b5arius_starts_preclinical_study_for_cancer/ 2018-07-04T14:14:16+00:00 https://www.pharmaceutical-business-review.com/news/7d4bdakela_completes_patient_enrollment_for_midstage_/ 2018-07-04T14:14:16+00:00 https://www.pharmaceutical-business-review.com/news/7a4a6mylan_to_acquire_remainder_of_matrix__r/ 2018-07-04T14:14:17+00:00 https://www.pharmaceutical-business-review.com/news/dd4a7epicept_pain_drug_to_enter_latestage_t/ 2018-07-04T14:14:17+00:00 https://www.pharmaceutical-business-review.com/news/924afmetabolex_completes_enrollment_of_diabetes_drug_/ 2018-07-04T14:14:17+00:00 https://www.pharmaceutical-business-review.com/news/044bdamgen_completes_acquisition_of_i/ 2018-07-04T14:14:17+00:00 https://www.pharmaceutical-business-review.com/news/fd4b9medimmune_advances_potential_treatment_for_/ 2018-07-04T14:14:19+00:00 https://www.pharmaceutical-business-review.com/news/54497takedas_hypertension_compound_enters_phase_iii_t/ 2018-07-04T14:14:20+00:00 https://www.pharmaceutical-business-review.com/news/2849aimmuneregen_and_virion_continue_testing_flu_cotrea/ 2018-07-04T14:14:20+00:00 https://www.pharmaceutical-business-review.com/news/144a6antares_and_jazz_to_jointly_develop_cns_trea/ 2018-07-04T14:14:20+00:00 https://www.pharmaceutical-business-review.com/news/cc49caffiris_begins_clinical_testing_of_alzheimers_va/ 2018-07-04T14:14:20+00:00 https://www.pharmaceutical-business-review.com/news/00485cougar_biotechnology_gets_fda_backing_for_cancer_drug_/ 2018-07-04T14:14:20+00:00 https://www.pharmaceutical-business-review.com/news/cd49cjj_unit_and_par_settle_patent_infringement_litig/ 2018-07-04T14:14:21+00:00 https://www.pharmaceutical-business-review.com/news/b44adgsks_cervical_cancer_vaccine_backed_/ 2018-07-04T14:14:21+00:00 https://www.pharmaceutical-business-review.com/news/a04b2md_biosciences_sees_progress_in_arthritomab_arthritis_/ 2018-07-04T14:14:21+00:00 https://www.pharmaceutical-business-review.com/news/a54b8abbott_q2_profit_up_62_on_strong_/ 2018-07-04T14:14:21+00:00 https://www.pharmaceutical-business-review.com/news/634bdroche_reports_profit_increase_appoints_ne/ 2018-07-04T14:14:23+00:00 https://www.pharmaceutical-business-review.com/news/3f487arena_initiates_phase_i_trial_of_thrombosis_trea/ 2018-07-04T14:14:23+00:00 https://www.pharmaceutical-business-review.com/news/e4482tibotec_submits_new_drug_application_for_hiv_trea/ 2018-07-04T14:14:23+00:00 https://www.pharmaceutical-business-review.com/news/biocon_and_invitrogen_strike_insulin_supply_deal/ 2018-07-04T14:14:24+00:00 https://www.pharmaceutical-business-review.com/news/e74bdmerck_transfers_nonus_niaspan_drug_rights_to_a/ 2018-07-04T14:14:24+00:00 https://www.pharmaceutical-business-review.com/news/b948dfda_grants_fast_track_designation_to_cardium_heart_th/ 2018-07-04T14:14:24+00:00 https://www.pharmaceutical-business-review.com/news/cc4b3new_study_questions_safety_profile_of_gsk_diabetes/ 2018-07-04T14:14:24+00:00 https://www.pharmaceutical-business-review.com/news/434bcmpex_initiates_phase_ib_cystic_fibrosis_drug_/ 2018-07-04T14:14:24+00:00 https://www.pharmaceutical-business-review.com/news/3a486basilea_superbug_drug_application_accepted_by_author/ 2018-07-04T14:14:25+00:00 https://www.pharmaceutical-business-review.com/news/9b4b4protox_strikes_manufacturing_deal_with_/ 2018-07-04T14:14:25+00:00 https://www.pharmaceutical-business-review.com/news/134bdcrucell_establishes_vaccine_and_protein_business_/ 2018-07-04T14:14:28+00:00 https://www.pharmaceutical-business-review.com/news/f44a6pharmacopeia_advances_first_therapeutic_program_wit/ 2018-07-04T14:14:29+00:00 https://www.pharmaceutical-business-review.com/news/fe4b1orchestra_therapeutics_discontinues_hiv_vaccine_development_pr/ 2018-07-04T14:14:29+00:00 https://www.pharmaceutical-business-review.com/news/f94a2penwest_and_edison_partner_for_neurological_disorder_trea/ 2018-07-04T14:14:29+00:00 https://www.pharmaceutical-business-review.com/news/b9497pfizer_profit_nosedives_lipitor_hurt_by_generic_compet/ 2018-07-04T14:14:29+00:00 https://www.pharmaceutical-business-review.com/news/f0497older_cheaper_diabetes_drugs_effective_study_/ 2018-07-04T14:14:29+00:00 https://www.pharmaceutical-business-review.com/news/99488sanofi_obesity_pill_set_for_european_safety_asses/ 2018-07-04T14:14:30+00:00 https://www.pharmaceutical-business-review.com/news/604bfacambis_influenza_vaccine_enters_ph/ 2018-07-04T14:14:30+00:00 https://www.pharmaceutical-business-review.com/news/864aaus_kids_immunization_project_adopts_merck_vac/ 2018-07-04T14:14:30+00:00 https://www.pharmaceutical-business-review.com/news/524b7pipex_begins_multiple_sclerosis_drug_/ 2018-07-04T14:14:30+00:00 https://www.pharmaceutical-business-review.com/news/924bamillennium_begins_pivotal_multiple_myeloma_drug_/ 2018-07-04T14:14:33+00:00 https://www.pharmaceutical-business-review.com/news/264b0neuroptix_receives_milestone_payment_from_/ 2018-07-04T14:14:34+00:00 https://www.pharmaceutical-business-review.com/news/c9487schwarz_pharma_and_ucb_launch_parkinsons_disease/ 2018-07-04T14:14:34+00:00 https://www.pharmaceutical-business-review.com/news/d6493roche_and_biocryst_begin_psoriasis_drug_/ 2018-07-04T14:14:34+00:00 https://www.pharmaceutical-business-review.com/news/7c488novartis_cuts_sales_forecast_diabetes_drug_approval_de/ 2018-07-04T14:14:34+00:00 https://www.pharmaceutical-business-review.com/news/c54b5hollisedens_diabetes_drug_successful_in_phase_i_/ 2018-07-04T14:14:34+00:00 https://www.pharmaceutical-business-review.com/news/fa495glycovaxyn_raises_funds_for_conjugated_vaccine_develo/ 2018-07-04T14:14:35+00:00 https://www.pharmaceutical-business-review.com/news/3d490new_uk_biotechnology_facility_o/ 2018-07-04T14:14:35+00:00 https://www.pharmaceutical-business-review.com/news/6b4baarpidas_superbug_treatment_found_to_be_effe/ 2018-07-04T14:14:35+00:00 https://www.pharmaceutical-business-review.com/news/89492idenix_scraps_development_of_hepatitis/ 2018-07-04T14:14:35+00:00 https://www.pharmaceutical-business-review.com/news/424b3vernalis_makes_progress_with_pain/ 2018-07-04T14:14:37+00:00 https://www.pharmaceutical-business-review.com/news/34485jazz_pays_20_million_to_settle_drug_laws/ 2018-07-04T14:14:37+00:00 https://www.pharmaceutical-business-review.com/news/3448fprotalix_receives_approval_for_gaucher_disease_/ 2018-07-04T14:14:38+00:00 https://www.pharmaceutical-business-review.com/news/ab4a5erbitux_fails_in_lung_cancer_/ 2018-07-04T14:14:38+00:00 https://www.pharmaceutical-business-review.com/news/c74a0pharmasset_and_roche_initiate_studies_to_advance_hepatitis/ 2018-07-04T14:14:38+00:00 https://www.pharmaceutical-business-review.com/news/8c4addor_biopharma_initiates_orbec_phase_ii_/ 2018-07-04T14:14:39+00:00 https://www.pharmaceutical-business-review.com/news/ee4b0lab_international_reports_positive_results_for_growth_ho/ 2018-07-04T14:14:39+00:00 https://www.pharmaceutical-business-review.com/news/fb4b3patient_recruitment_completed_for_pivotal_study_of_r/ 2018-07-04T14:14:39+00:00 https://www.pharmaceutical-business-review.com/news/cc4b2avalon_initiates_phase_ii_cancer_drug_/ 2018-07-04T14:14:39+00:00 https://www.pharmaceutical-business-review.com/news/1b4adariad_and_merck_partner_for_cancer_mtor_inhi/ 2018-07-04T14:14:39+00:00 https://www.pharmaceutical-business-review.com/news/074adgtxs_prostrate_cancer_drug_trial_on_c/ 2018-07-04T14:14:43+00:00 https://www.pharmaceutical-business-review.com/news/764b5lotus_reports_on_its_hepatitis_b_drug_develo/ 2018-07-04T14:14:43+00:00 https://www.pharmaceutical-business-review.com/news/f54a7lifecycle_pharma_to_initiate_phase_ii_trial_of_lcpat/ 2018-07-04T14:14:43+00:00 https://www.pharmaceutical-business-review.com/news/964b5ym_biosciences_painkiller_successful_in_/ 2018-07-04T14:14:43+00:00 https://www.pharmaceutical-business-review.com/news/4948dlabopharm_completes_south_korean_licensing_and_distribution_deal_for_tra/ 2018-07-04T14:14:44+00:00 https://www.pharmaceutical-business-review.com/news/434bfcarmen_electra_to_promote_antiacne_trea/ 2018-07-04T14:14:44+00:00 https://www.pharmaceutical-business-review.com/news/e3488tracon_begins_phase_i_trial_of_cancer_treatment_ant/ 2018-07-04T14:14:44+00:00 https://www.pharmaceutical-business-review.com/news/a04afantisoma_drops_ovarian_cancer/ 2018-07-04T14:14:44+00:00 https://www.pharmaceutical-business-review.com/news/8849dventana_rejects_roches_3_billion_/ 2018-07-04T14:14:44+00:00 https://www.pharmaceutical-business-review.com/news/2e4bdcell_therapeutics_lymphoma_drug_lowers_side_af/ 2018-07-04T14:14:45+00:00 https://www.pharmaceutical-business-review.com/news/b24baperegrine_to_initiate_lung_cancer_drug_/ 2018-07-04T14:14:47+00:00 https://www.pharmaceutical-business-review.com/news/71491entremed_strikes_research_deal_with_university_for_panzem_mecha/ 2018-07-04T14:14:47+00:00 https://www.pharmaceutical-business-review.com/news/0d4bdgenerex_enters_licensing_agreement_for_insulin_/ 2018-07-04T14:14:47+00:00 https://www.pharmaceutical-business-review.com/news/b649cpipex_acquires_drug_for_blindness_trea/ 2018-07-04T14:14:47+00:00 https://www.pharmaceutical-business-review.com/news/39491depomeds_shingles_pain_drug_fails_in_pivotal_/ 2018-07-04T14:14:48+00:00 https://www.pharmaceutical-business-review.com/news/2549fpfizer_wins_lipitor_patent_case_against_ra/ 2018-07-04T14:14:48+00:00 https://www.pharmaceutical-business-review.com/news/684a0pieris_reports_positive_progress_for_asthma_drug_candi/ 2018-07-04T14:14:48+00:00 https://www.pharmaceutical-business-review.com/news/184a4menarini_ready_for_ovarian_cancer_vaccine_phase_iii_/ 2018-07-04T14:14:48+00:00 https://www.pharmaceutical-business-review.com/news/284b4merck__co_pulls_out_of_estrogen_compound_collaboratio/ 2018-07-04T14:14:48+00:00 https://www.pharmaceutical-business-review.com/news/5a490prometics_anemia_drug_successful_in_clinical_tri/ 2018-07-04T14:14:49+00:00 https://www.pharmaceutical-business-review.com/news/ef4b1novavax_licenses_wyeths_technology_for_flu_vac/ 2018-07-04T14:14:51+00:00 https://www.pharmaceutical-business-review.com/news/0949cgeron_starts_clinical_trial_for_lung_cancer/ 2018-07-04T14:14:51+00:00 https://www.pharmaceutical-business-review.com/news/d44a0drug_royalty_corporation_acquires_flumist_roya/ 2018-07-04T14:14:51+00:00 https://www.pharmaceutical-business-review.com/news/c248fwarner_chilcott_paratek_partner_for_acne_and_rosacea_a/ 2018-07-04T14:14:52+00:00 https://www.pharmaceutical-business-review.com/news/7b482spectrum_pharmaceuticals_files_inda_for_cancer/ 2018-07-04T14:14:52+00:00 https://www.pharmaceutical-business-review.com/news/cd4bagsk_asthma_inhaler_gets_european_license_exte/ 2018-07-04T14:14:52+00:00 https://www.pharmaceutical-business-review.com/news/174b5manhattan_pharmaceuticals_to_discontinue_obesity_drug_pr/ 2018-07-04T14:14:52+00:00 https://www.pharmaceutical-business-review.com/news/884b6roches_ra_drug_successful_in_phase_iii_/ 2018-07-04T14:14:53+00:00 https://www.pharmaceutical-business-review.com/news/3f4afmerz_targets_alzheimers_drug_develo/ 2018-07-04T14:14:53+00:00 https://www.pharmaceutical-business-review.com/news/f248euk_government_makes_cancer_drug_u/ 2018-07-04T14:14:53+00:00 https://www.pharmaceutical-business-review.com/news/3249bnorthwest_biotherapeutics_gets_swiss_approval_for_brain_cancer_va/ 2018-07-04T14:14:56+00:00 https://www.pharmaceutical-business-review.com/news/b64adbayer_blood_clot_drug_found_to_be_superior_to_lo/ 2018-07-04T14:14:56+00:00 https://www.pharmaceutical-business-review.com/news/1a48egenzyme_c_difficile_therapy_fails_study/ 2018-07-04T14:14:56+00:00 https://www.pharmaceutical-business-review.com/news/834aflow_pollen_count_disrupts_cobalis_hayfever_/ 2018-07-04T14:14:56+00:00 https://www.pharmaceutical-business-review.com/news/e0487sanofi_study_shows_extended_lovenox_regimen_reduces_vte/ 2018-07-04T14:14:56+00:00 https://www.pharmaceutical-business-review.com/news/484b7roche_and_alnylam_form_alliance_on_rnai_therape/ 2018-07-04T14:14:56+00:00 https://www.pharmaceutical-business-review.com/news/2c490ym_biosciences_reports_positive_results_for_tumor_trea/ 2018-07-04T14:14:57+00:00 https://www.pharmaceutical-business-review.com/news/20497silence_and_astrazeneca_to_collaborate_on_sirna_techn/ 2018-07-04T14:14:57+00:00 https://www.pharmaceutical-business-review.com/news/6649dtibotec_reports_on_promising_aids_drug_combo_/ 2018-07-04T14:14:57+00:00 https://www.pharmaceutical-business-review.com/news/a14acfda_warning_on_rocephin_calcium_combination_in_b/ 2018-07-04T14:14:57+00:00 https://www.pharmaceutical-business-review.com/news/ed485heritage_and_granules_form_generics_alliance_for_us_m/ 2018-07-04T14:15:00+00:00 https://www.pharmaceutical-business-review.com/news/cc4bcscientists_find_brain_pathway_of_depression_in/ 2018-07-04T14:15:00+00:00 https://www.pharmaceutical-business-review.com/news/e24bepaladin_cleared_to_market_oral_contraceptive_in_c/ 2018-07-04T14:15:00+00:00 https://www.pharmaceutical-business-review.com/news/ab4b5roche_takes_ventana_to_court_over_share_/ 2018-07-04T14:15:00+00:00 https://www.pharmaceutical-business-review.com/news/b94b5bms_ixabepilone_shows_activity_in_breast_cancer_pat/ 2018-07-04T14:15:01+00:00 https://www.pharmaceutical-business-review.com/news/ea490bms_ends_hiv_alliance_with_me/ 2018-07-04T14:15:01+00:00 https://www.pharmaceutical-business-review.com/news/654bftibotec_drugs_fight_resistant_hiv_in_/ 2018-07-04T14:15:01+00:00 https://www.pharmaceutical-business-review.com/news/a34b6viropharma_starts_pivotal_camvia_study_in_liver_transplant_pat/ 2018-07-04T14:15:01+00:00 https://www.pharmaceutical-business-review.com/news/f749cpharmaxis_completes_phase_iii_bronchitol_/ 2018-07-04T14:15:01+00:00 https://www.pharmaceutical-business-review.com/news/874aahiv_drug_welltolerated_in_midstage_trial_says_/ 2018-07-04T14:15:02+00:00 https://www.pharmaceutical-business-review.com/news/fd4bfgenzyme_says_osteoarthritis_treatment_misses_trial_/ 2018-07-04T14:15:04+00:00 https://www.pharmaceutical-business-review.com/news/fe492astrazeneca_distribution_scheme_on_hol/ 2018-07-04T14:15:04+00:00 https://www.pharmaceutical-business-review.com/news/f2484supergen_begins_phase_i_trial_of_cancer/ 2018-07-04T14:15:04+00:00 https://www.pharmaceutical-business-review.com/news/65493genaera_drops_cystic_fibrosis_and_prostate_cancer_t/ 2018-07-04T14:15:05+00:00 https://www.pharmaceutical-business-review.com/news/52493brazil_receives_reduced_kaletra_/ 2018-07-04T14:15:05+00:00 https://www.pharmaceutical-business-review.com/news/09493biomira_seeks_fda_clearance_for_cancer_drug_t/ 2018-07-04T14:15:05+00:00 https://www.pharmaceutical-business-review.com/news/514b0nps_pharmaceuticals_sells_two_facil/ 2018-07-04T14:15:05+00:00 https://www.pharmaceutical-business-review.com/news/5848dmedimmune_tests_respiratory_vaccine_on_young_children/ 2018-07-04T14:15:05+00:00 https://www.pharmaceutical-business-review.com/news/52480avanir_sells_schizophrenia_drug_cfo_re/ 2018-07-04T14:15:06+00:00 https://www.pharmaceutical-business-review.com/news/e94bfepicept_adds_study_center_to_cancer_/ 2018-07-04T14:15:06+00:00 https://www.pharmaceutical-business-review.com/news/914a1tysabri_recommended_by/ 2018-07-04T14:15:08+00:00 https://www.pharmaceutical-business-review.com/news/1b488skin_rash_signifies_improved_survival_rate_in_cancer_say_resear/ 2018-07-04T14:15:08+00:00 https://www.pharmaceutical-business-review.com/news/3d4a5gtx_starts_trial_for_cancer/ 2018-07-04T14:15:09+00:00 https://www.pharmaceutical-business-review.com/news/9349froche_receives_fda_approval_for_lower_dose_ta/ 2018-07-04T14:15:09+00:00 https://www.pharmaceutical-business-review.com/news/bb4b0lexicon_develops_antibodies_for_potential_heart_disease_trea/ 2018-07-04T14:15:09+00:00 https://www.pharmaceutical-business-review.com/news/9b4a7fda_gives_genentechs_asthma_drug_black_box_/ 2018-07-04T14:15:09+00:00 https://www.pharmaceutical-business-review.com/news/9b48eroxane_gets_fda_approval_for_generic_lami/ 2018-07-04T14:15:10+00:00 https://www.pharmaceutical-business-review.com/news/cd49emylan_gets_final_fda_approval_for_generic_la/ 2018-07-04T14:15:10+00:00 https://www.pharmaceutical-business-review.com/news/0548emaxygen_begins_midstage_breast_cancer_drug_/ 2018-07-04T14:15:10+00:00 https://www.pharmaceutical-business-review.com/news/1a4a3sciele_pharma_seeks_approval_for_new_sular_formul/ 2018-07-04T14:15:10+00:00 https://www.pharmaceutical-business-review.com/news/fa4a6dor_biopharma_reports_positive_botulinum_vaccine_re/ 2018-07-04T14:15:12+00:00 https://www.pharmaceutical-business-review.com/news/ab4a7biogen_idec_and_cardiokine_partner_to_develop_heart_failure/ 2018-07-04T14:15:12+00:00 https://www.pharmaceutical-business-review.com/news/8b4b3ceragenix_compound_shows_promise_for_treating_cystic_fibrosis_infec/ 2018-07-04T14:15:12+00:00 https://www.pharmaceutical-business-review.com/news/eb49cencouraging_results_in_ablynxs_thrombosis_drug_/ 2018-07-04T14:15:13+00:00 https://www.pharmaceutical-business-review.com/news/a04a8shire_files_vyvanse_drug_for_the_treatment_of_adhd_in_a/ 2018-07-04T14:15:13+00:00 https://www.pharmaceutical-business-review.com/news/7948agalapagos_expands_osteoarthritis_alliance_with_glaxosmith/ 2018-07-04T14:15:13+00:00 https://www.pharmaceutical-business-review.com/news/ef4a2teva_gets_fda_approval_for_generic_no/ 2018-07-04T14:15:13+00:00 https://www.pharmaceutical-business-review.com/news/8548aakorn_seeks_us_marketing_permission_for_ocular_anest/ 2018-07-04T14:15:13+00:00 https://www.pharmaceutical-business-review.com/news/be4adbristolmyers_squibb_selling_asian_brands_to/ 2018-07-04T14:15:13+00:00 https://www.pharmaceutical-business-review.com/news/3c48aadvanced_life_sciencess_antibiotic_meets_study_endp/ 2018-07-04T14:15:14+00:00 https://www.pharmaceutical-business-review.com/news/2249athe_medicines_company_regains_rights_to_anticoag/ 2018-07-04T14:15:21+00:00 https://www.pharmaceutical-business-review.com/news/a049clabopharm_says_fda_may_require_another_trial_for_pain/ 2018-07-04T14:15:21+00:00 https://www.pharmaceutical-business-review.com/news/a2487genmab_regains_rights_to_antibody_from_merck/ 2018-07-04T14:15:21+00:00 https://www.pharmaceutical-business-review.com/news/ee4b7nicox_initiates_third_naproxcinod_phase_iii_/ 2018-07-04T14:15:22+00:00 https://www.pharmaceutical-business-review.com/news/cd4afjjs_schizophrenia_drug_granted_eu_app/ 2018-07-04T14:15:22+00:00 https://www.pharmaceutical-business-review.com/news/32494coley_licenses_hepatitis_b_vaccine_to_dy/ 2018-07-04T14:15:22+00:00 https://www.pharmaceutical-business-review.com/news/1749eavicena_to_conduct_trial_for_huntingtons_disease/ 2018-07-04T14:15:22+00:00 https://www.pharmaceutical-business-review.com/news/7b491combinatorx_discontinues_arthritis_drug_develo/ 2018-07-04T14:15:22+00:00 https://www.pharmaceutical-business-review.com/news/11489cephalon_to_file_leukemia_drug_applic/ 2018-07-04T14:15:23+00:00 https://www.pharmaceutical-business-review.com/news/72493titan_completes_patient_enrolment_for_parkinsons_drug_/ 2018-07-04T14:15:23+00:00 https://www.pharmaceutical-business-review.com/news/024a0cytokinetics_breast_cancer_drug_meets_trial_objec/ 2018-07-04T14:15:24+00:00 https://www.pharmaceutical-business-review.com/news/cf492transition_therapeutics_reports_positive_results_for_diabetes/ 2018-07-04T14:15:25+00:00 https://www.pharmaceutical-business-review.com/news/cf48estem_cell_breakthrough_could_accelerate_res/ 2018-07-04T14:15:25+00:00 https://www.pharmaceutical-business-review.com/news/a848abiovest_reports_encouraging_interim_results_for_cancer_va/ 2018-07-04T14:15:25+00:00 https://www.pharmaceutical-business-review.com/news/e4492millennium_reports_high_survival_rates_for_patients_on_ve/ 2018-07-04T14:15:25+00:00 https://www.pharmaceutical-business-review.com/news/574a4pfizer_starts_pivotal_study_for_colorectal_cancer/ 2018-07-04T14:15:25+00:00 https://www.pharmaceutical-business-review.com/news/66488teva_announces_tentative_approval_of_herpes_ta/ 2018-07-04T14:15:26+00:00 https://www.pharmaceutical-business-review.com/news/a0499speedel_reports_positive_phase_ii_results_for_hypertension_d/ 2018-07-04T14:15:26+00:00 https://www.pharmaceutical-business-review.com/news/c8489bayer_and_onyx_seek_approval_for_liver_cancer/ 2018-07-04T14:15:26+00:00 https://www.pharmaceutical-business-review.com/news/76484sciclone_begins_phase_ii_trial_of_hepatitis_c_d/ 2018-07-04T14:15:26+00:00 https://www.pharmaceutical-business-review.com/news/5e484takeda_applies_for_actos_to_be_taken_with_insulin_in_ja/ 2018-07-04T14:15:29+00:00 https://www.pharmaceutical-business-review.com/news/df494sanofis_cancer_drug_gets_priority_review_in/ 2018-07-04T14:15:29+00:00 https://www.pharmaceutical-business-review.com/news/6d49ctranzyme_reports_positive_data_for_diabetic_gastroparesis_ag/ 2018-07-04T14:15:29+00:00 https://www.pharmaceutical-business-review.com/news/da4afaspreva_roche_say_cellcept_failed_to_meet_study/ 2018-07-04T14:15:30+00:00 https://www.pharmaceutical-business-review.com/news/a4491isotechnika_enrolls_last_patient_in_transplantation_drug_/ 2018-07-04T14:15:30+00:00 https://www.pharmaceutical-business-review.com/news/5b4aakoronis_hiv_drug_in_phase_ii_te/ 2018-07-04T14:15:30+00:00 https://www.pharmaceutical-business-review.com/news/obecure_completes_patient_treatment_in_obesity_trial/ 2018-07-04T14:15:30+00:00 https://www.pharmaceutical-business-review.com/news/diabetes_group_president_questions_avandia_study/ 2018-07-04T14:15:30+00:00 https://www.pharmaceutical-business-review.com/news/fd4b3actavis_launches_generic_adalat_in_t/ 2018-07-04T14:15:31+00:00 https://www.pharmaceutical-business-review.com/news/1d4abreplidyne_reports_positive_phase_i_results_for_antib/ 2018-07-04T14:15:31+00:00 https://www.pharmaceutical-business-review.com/news/b1497skyepharma_and_somnus_to_develop_sleep/ 2018-07-04T14:15:33+00:00 https://www.pharmaceutical-business-review.com/news/9e486pharmion_submits_satraplatin_combination_for_eu_app/ 2018-07-04T14:15:34+00:00 https://www.pharmaceutical-business-review.com/news/39484wyeth_licenses_drug_targets_from_gala/ 2018-07-04T14:15:34+00:00 https://www.pharmaceutical-business-review.com/news/9649aucb_and_biogen_idec_begin_ms_/ 2018-07-04T14:15:34+00:00 https://www.pharmaceutical-business-review.com/news/2c4b6skyepharma_licenses_sleep_therapeutic_to_s/ 2018-07-04T14:15:34+00:00 https://www.pharmaceutical-business-review.com/news/ee4a1ucb_and_biogen_begin_ms_drug_phase_ii_/ 2018-07-04T14:15:34+00:00 https://www.pharmaceutical-business-review.com/news/7e488us_supreme_court_will_not_review_tamoxifen/ 2018-07-04T14:15:35+00:00 https://www.pharmaceutical-business-review.com/news/alzheimers_drug_access_issue_goes_to_court/ 2018-07-04T14:15:35+00:00 https://www.pharmaceutical-business-review.com/news/neurogen_reports_positive_results_for_insomnia_drug_in_clinical_trials/ 2018-07-04T14:15:35+00:00 https://www.pharmaceutical-business-review.com/news/6f49ftheravances_constipation_drug_meets_phase_ii_trial_/ 2018-07-04T14:15:35+00:00 https://www.pharmaceutical-business-review.com/news/b64beantidepressants_linked_to_weak_bones_in_el/ 2018-07-04T14:15:38+00:00 https://www.pharmaceutical-business-review.com/news/7d497tobacco_firm_to_pursue_neurological_drug_develo/ 2018-07-04T14:15:38+00:00 https://www.pharmaceutical-business-review.com/news/b848croche_and_toyama_chemical_ink_licensing_agreement_to_develop_arthritis/ 2018-07-04T14:15:39+00:00 https://www.pharmaceutical-business-review.com/news/gpc_biotech_signs_deal_with_yakult_for_japanese_cancer_drug/ 2018-07-04T14:15:39+00:00 https://www.pharmaceutical-business-review.com/news/0a493ranbaxy_launches_pravastatin_sodium_tablets_in_t/ 2018-07-04T14:15:39+00:00 https://www.pharmaceutical-business-review.com/news/3d48ascheringplough_gets_eu_approval_for_hepatitis_chiv/ 2018-07-04T14:15:39+00:00 https://www.pharmaceutical-business-review.com/news/604bastudy_shows_byetta_reduces_cardiovascular_risk_factors_in_type_2_diab/ 2018-07-04T14:15:39+00:00 https://www.pharmaceutical-business-review.com/news/cd4acearlier_initiation_of_tamiflu_speeds_up_recovery_of_children_wit/ 2018-07-04T14:15:40+00:00 https://www.pharmaceutical-business-review.com/news/ec480cholesterollowering_drugs_could_prevent_diabetic_nerve_damage_study_/ 2018-07-04T14:15:40+00:00 https://www.pharmaceutical-business-review.com/news/9d4a9aurobindo_pharma_gets_tentative_fda_approval_for_quin/ 2018-07-04T14:15:40+00:00 https://www.pharmaceutical-business-review.com/news/oncolys_biopharma_and_tacere_therapeutics_to_develop_hepatitis_c_drug/ 2018-07-04T14:15:54+00:00 https://www.pharmaceutical-business-review.com/news/c348eakorn_and_cipla_partner_for_drug_develo/ 2018-07-04T14:15:54+00:00 https://www.pharmaceutical-business-review.com/news/874b0pfizers_lyrica_receives_fda_app/ 2018-07-04T14:15:54+00:00 https://www.pharmaceutical-business-review.com/news/524bdskyepharma_inc_changes_name_to_pacira_pharmaceut/ 2018-07-04T14:15:54+00:00 https://www.pharmaceutical-business-review.com/news/8c49fresearchers_find_new_compound_to_treat_fungal_infec/ 2018-07-04T14:15:55+00:00 https://www.pharmaceutical-business-review.com/news/5c49chigh_blood_levels_of_urate_linked_to_lower_risk_of_parkinsons_di/ 2018-07-04T14:15:55+00:00 https://www.pharmaceutical-business-review.com/news/8b496roches_tamiflu_drug_could_halve_flupandemic_death/ 2018-07-04T14:15:55+00:00 https://www.pharmaceutical-business-review.com/news/9b4b2researchers_isolate_new_risk_marker_for_overweight_chi/ 2018-07-04T14:15:55+00:00 https://www.pharmaceutical-business-review.com/news/974a1ranbaxy_receives_tentative_approval_for_hypertension_ta/ 2018-07-04T14:15:56+00:00 https://www.pharmaceutical-business-review.com/news/d34a1omega3_found_to_help_combat_alzheimers_sym/ 2018-07-04T14:15:56+00:00 https://www.pharmaceutical-business-review.com/news/f048ddigirad_divests_arizona_nevada_service_hubs_to_antigua_medical_ser/ 2018-07-04T14:16:33+00:00 https://www.pharmaceutical-business-review.com/news/7948ftyrx_names_new_vice_president_of_/ 2018-07-04T14:16:33+00:00 https://www.pharmaceutical-business-review.com/news/0f499savara_names_three_new_board_me/ 2018-07-04T14:16:33+00:00 https://www.pharmaceutical-business-review.com/news/49495epix_pharmaceuticals_names_new_president_an/ 2018-07-04T14:16:34+00:00 https://www.pharmaceutical-business-review.com/news/6e4b6arqule_expands_cancer_drug_development_pr/ 2018-07-04T14:16:34+00:00 https://www.pharmaceutical-business-review.com/news/704a4glaxosmithkline_drug_for_rare_leukemias_recommended_for_app/ 2018-07-04T14:17:03+00:00 https://www.pharmaceutical-business-review.com/news/e84a8alexions_blood_disorder_drug_approved_in_e/ 2018-07-04T14:17:04+00:00 https://www.pharmaceutical-business-review.com/news/7c482encorium_signs_38_million_contract_for_shingles_clinical_/ 2018-07-04T14:17:04+00:00 https://www.pharmaceutical-business-review.com/news/69496seasquirt_drug_could_targets_cancer_t/ 2018-07-04T14:17:04+00:00 https://www.pharmaceutical-business-review.com/news/44494pfizer_discontinues_lung_cancer_drug_t/ 2018-07-04T14:17:04+00:00 https://www.pharmaceutical-business-review.com/news/cc49fnovartis_receives_fda_approval_for_blood_pressure_med/ 2018-07-04T14:17:06+00:00 https://www.pharmaceutical-business-review.com/news/ad48cshire_receives_fda_approval_for_adhd/ 2018-07-04T14:17:06+00:00 https://www.pharmaceutical-business-review.com/news/e74bdpfizer_receives_fda_approvable_letter_for_hiv/ 2018-07-04T14:17:06+00:00 https://www.pharmaceutical-business-review.com/news/a049auk_government_panel_backs_cervical_cancer_jab_for_gir/ 2018-07-04T14:17:07+00:00 https://www.pharmaceutical-business-review.com/news/dc4a1johnson__johnson_lose_drug_patch_cas/ 2018-07-04T14:17:07+00:00 https://www.pharmaceutical-business-review.com/news/c64bapharmos_starts_midstage_ibs_/ 2018-07-04T14:17:10+00:00 https://www.pharmaceutical-business-review.com/news/30499fda_approves_galdermas_stronger_acne_formul/ 2018-07-04T14:17:10+00:00 https://www.pharmaceutical-business-review.com/news/5e4aeshire_buys_rights_to_scar_reduction/ 2018-07-04T14:17:10+00:00 https://www.pharmaceutical-business-review.com/news/1a4b1bayer_and_onyx_seek_european_approval_for_liver_cancer/ 2018-07-04T14:17:10+00:00 https://www.pharmaceutical-business-review.com/news/b148eorganons_contraceptive_completes_european_authorizat/ 2018-07-04T14:17:11+00:00 https://www.pharmaceutical-business-review.com/news/f4496roche_set_to_buy_nimblegen_for_2725_mi/ 2018-07-04T14:17:14+00:00 https://www.pharmaceutical-business-review.com/news/ba488inovio_reports_positive_results_for_secta_th/ 2018-07-04T14:17:14+00:00 https://www.pharmaceutical-business-review.com/news/7a4babristolmyers_arthritis_drug_shows_potential_in_treating_chi/ 2018-07-04T14:17:14+00:00 https://www.pharmaceutical-business-review.com/news/c9490fda_rejects_encysives_thelin_for_third/ 2018-07-04T14:17:14+00:00 https://www.pharmaceutical-business-review.com/news/f04b7fda_approves_additional_delivery_for_sanofi_diabetes/ 2018-07-04T14:17:14+00:00 https://www.pharmaceutical-business-review.com/news/fb4aeperlegen_seeks_genes_responsible_for_actos_and_avandia_sideef/ 2018-07-04T14:17:17+00:00 https://www.pharmaceutical-business-review.com/news/be496amarillo_gains_funding_for_oral_interferon_therapy_/ 2018-07-04T14:17:18+00:00 https://www.pharmaceutical-business-review.com/news/584acscheringploughs_remicade_helps_spinal_arth/ 2018-07-04T14:17:18+00:00 https://www.pharmaceutical-business-review.com/news/5748anovo_nordisk_begins_phase_i_trial_of_hemophilia/ 2018-07-04T14:17:18+00:00 https://www.pharmaceutical-business-review.com/news/214affda_converts_telcyta_full_clinical_hold_to_partial/ 2018-07-04T14:17:18+00:00 https://www.pharmaceutical-business-review.com/news/watson_receives_fda_final_approval_for_generic_wellbutrin/ 2018-07-04T14:17:21+00:00 https://www.pharmaceutical-business-review.com/news/bc4a0scientists_discover_gene_linked_to_breast_c/ 2018-07-04T14:17:22+00:00 https://www.pharmaceutical-business-review.com/news/7f480us_government_awards_1325_million_for_flu_vaccine_produ/ 2018-07-04T14:17:22+00:00 https://www.pharmaceutical-business-review.com/news/694a1genmab_begins_phase_ii_study_for_cancer/ 2018-07-04T14:17:22+00:00 https://www.pharmaceutical-business-review.com/news/7e4a8roche_arthritis_drug_found_to_offer_improvement_over_standard/ 2018-07-04T14:17:22+00:00 https://www.pharmaceutical-business-review.com/news/cc482epicept_cancer_drug_shows_promise_in_animal_st/ 2018-07-04T14:17:25+00:00 https://www.pharmaceutical-business-review.com/news/6f493decode_reaches_settlement_with_philadelphia_hos/ 2018-07-04T14:17:25+00:00 https://www.pharmaceutical-business-review.com/news/6f4adsolvay_seeks_approval_for_androgel_in_/ 2018-07-04T14:17:26+00:00 https://www.pharmaceutical-business-review.com/news/cf4bcderma_sciences_receives_canadian_clearance_for_honeybased_dres/ 2018-07-04T14:17:26+00:00 https://www.pharmaceutical-business-review.com/news/704achuman_genomes_lupus_drug_shows_positive_results_in_pha/ 2018-07-04T14:17:26+00:00 https://www.pharmaceutical-business-review.com/news/4f4a7living_cell_starts_diabetes_/ 2018-07-04T14:17:28+00:00 https://www.pharmaceutical-business-review.com/news/6d49epluristems_stem_cell_therapy_shows_promise_for_parkinsons_di/ 2018-07-04T14:17:28+00:00 https://www.pharmaceutical-business-review.com/news/5548ducb_arthritis_drug_achieves_strong_results_in_phas/ 2018-07-04T14:17:28+00:00 https://www.pharmaceutical-business-review.com/news/c44a2fda_panel_rejects_sanofis_diet/ 2018-07-04T14:17:29+00:00 https://www.pharmaceutical-business-review.com/news/eb499lupin_receives_final_fda_approval_for_generic_/ 2018-07-04T14:17:29+00:00 https://www.pharmaceutical-business-review.com/news/364b1nice_recommends_lucentis_for_we/ 2018-07-04T14:17:33+00:00 https://www.pharmaceutical-business-review.com/news/ce486lilly_launches_research_effort_to_fig/ 2018-07-04T14:17:33+00:00 https://www.pharmaceutical-business-review.com/news/ae485american_oriental_to_buy_chinese_company_for_30_mi/ 2018-07-04T14:17:33+00:00 https://www.pharmaceutical-business-review.com/news/fc48dwarner_pays_55_million_to_settle_contraceptive_la/ 2018-07-04T14:17:33+00:00 https://www.pharmaceutical-business-review.com/news/e349fno_safety_concerns_found_for_biovest_va/ 2018-07-04T14:17:34+00:00 https://www.pharmaceutical-business-review.com/news/154bcwex_cleared_to_begin_latestage_pain_drug_/ 2018-07-04T14:17:37+00:00 https://www.pharmaceutical-business-review.com/news/9d494glaxosmithkline_pays_pharmacopeia_5_mi/ 2018-07-04T14:17:37+00:00 https://www.pharmaceutical-business-review.com/news/24483bradley_pharmaceuticals_launches_elestrin_estroge/ 2018-07-04T14:17:37+00:00 https://www.pharmaceutical-business-review.com/news/6f4afastion_receives_capital_boost_for_drug_develo/ 2018-07-04T14:17:37+00:00 https://www.pharmaceutical-business-review.com/news/3649dchroma_receives_ind_approval_fro/ 2018-07-04T14:17:38+00:00 https://www.pharmaceutical-business-review.com/news/594a6new_arthritis_drugs_mark_new_treatment_era_says_/ 2018-07-04T14:17:41+00:00 https://www.pharmaceutical-business-review.com/news/a14a8pharmaceutical_business_model_unsustainable_say/ 2018-07-04T14:17:41+00:00 https://www.pharmaceutical-business-review.com/news/3149epenwest_begins_midstage_trial_for_pain_pr/ 2018-07-04T14:17:41+00:00 https://www.pharmaceutical-business-review.com/news/f84a0idenix_combination_hepatitis_c_treatment_meets_trial_/ 2018-07-04T14:17:42+00:00 https://www.pharmaceutical-business-review.com/news/f4493sciele_pharma_completes_purchase_of_al/ 2018-07-04T14:17:42+00:00 https://www.pharmaceutical-business-review.com/news/8f4a3par_to_commercialize_immtechs_pneumonia_treatment_in_t/ 2018-07-04T14:17:44+00:00 https://www.pharmaceutical-business-review.com/news/234bdcombinatorx_and_angiotech_extend_rd_collabor/ 2018-07-04T14:17:44+00:00 https://www.pharmaceutical-business-review.com/news/c94b3bradley_launches_authorized_generic_/ 2018-07-04T14:17:45+00:00 https://www.pharmaceutical-business-review.com/news/c348aglaxosmithkline_launches_otc_diet/ 2018-07-04T14:17:45+00:00 https://www.pharmaceutical-business-review.com/news/1d4bdsunesis_reveals_strong_interim_results_for_cancer/ 2018-07-04T14:17:45+00:00 https://www.pharmaceutical-business-review.com/news/ef49bgeron_presents_promising_data_in_ongoing_leukemia_/ 2018-07-04T14:17:48+00:00 https://www.pharmaceutical-business-review.com/news/db480viventia_biotech_begins_phase_i_trial_of_cancer_ant/ 2018-07-04T14:17:48+00:00 https://www.pharmaceutical-business-review.com/news/3c494fda_reveals_suicidal_tendencies_related_to_sanofiaventis_obesity/ 2018-07-04T14:17:48+00:00 https://www.pharmaceutical-business-review.com/news/004a4barr_withdraws_challenge_of_zyprexa_zydis_p/ 2018-07-04T14:17:48+00:00 https://www.pharmaceutical-business-review.com/news/674bfneopharm_licenses_pulmonary_fibrosis_d/ 2018-07-04T14:17:49+00:00 https://www.pharmaceutical-business-review.com/news/184bapipex_trials_menopause_drug_/ 2018-07-04T14:17:51+00:00 https://www.pharmaceutical-business-review.com/news/5349ffda_delays_decision_on_sanofi_va/ 2018-07-04T14:17:51+00:00 https://www.pharmaceutical-business-review.com/news/2b496propharmaceuticals_seeks_fda_approval_for_cancer/ 2018-07-04T14:17:52+00:00 https://www.pharmaceutical-business-review.com/news/e7483imclone_and_bms_seek_extra_information_on_erbitux_/ 2018-07-04T14:17:52+00:00 https://www.pharmaceutical-business-review.com/news/714b3merck_kgaa_and_archemix_to_collab/ 2018-07-04T14:17:52+00:00 https://www.pharmaceutical-business-review.com/news/33483ipsens_reformulation_fails_to_meet_trial/ 2018-07-04T14:17:54+00:00 https://www.pharmaceutical-business-review.com/news/76494arcehmix_completes_successful_earlystage_trial_for_aptamer_th/ 2018-07-04T14:17:55+00:00 https://www.pharmaceutical-business-review.com/news/e6492endos_menstrual_migraine_treatment_better_than_placebo_in_/ 2018-07-04T14:17:55+00:00 https://www.pharmaceutical-business-review.com/news/c44b9organon_reports_faster_action_for/ 2018-07-04T14:17:55+00:00 https://www.pharmaceutical-business-review.com/news/8b49bscios_initiates_natrecor_trial_in_heart_fa/ 2018-07-04T14:17:55+00:00 https://www.pharmaceutical-business-review.com/news/154addebiopharm_offers_encouraging_data_for_alzheimers_trea/ 2018-07-04T14:17:57+00:00 https://www.pharmaceutical-business-review.com/news/e448eavanir_releases_positive_results_for_pain/ 2018-07-04T14:17:58+00:00 https://www.pharmaceutical-business-review.com/news/13499virexx_reports_positive_results_from_ovarian_cancer_/ 2018-07-04T14:17:58+00:00 https://www.pharmaceutical-business-review.com/news/fb4a0nupathes_migraine_patch_reaches_trial/ 2018-07-04T14:17:58+00:00 https://www.pharmaceutical-business-review.com/news/534abcallisto_sues_former_exec/ 2018-07-04T14:17:58+00:00 https://www.pharmaceutical-business-review.com/news/gilead_hepatitis_b_drug_reaches_phase_iii_objective/ 2018-07-04T14:18:03+00:00 https://www.pharmaceutical-business-review.com/news/2948cscheringploughs_cholesterol_drug_approved_in_/ 2018-07-04T14:18:03+00:00 https://www.pharmaceutical-business-review.com/news/44488humira_approved_in_eu_for_crohns_di/ 2018-07-04T14:18:03+00:00 https://www.pharmaceutical-business-review.com/news/084afym_biosciences_gets_goahead_for_phase_ii_brain_cancer_drug_/ 2018-07-04T14:18:04+00:00 https://www.pharmaceutical-business-review.com/news/0249eeu_approval_for_remicade_in_chi/ 2018-07-04T14:18:04+00:00 https://www.pharmaceutical-business-review.com/news/74498pharmos_settles_lawsuits_over_brain/ 2018-07-04T14:18:07+00:00 https://www.pharmaceutical-business-review.com/news/93483eli_lilly_to_appeal_zyprexa_patent_ru/ 2018-07-04T14:18:07+00:00 https://www.pharmaceutical-business-review.com/news/25490innovives_leukemia_drug_receives_fast_track_status_fro/ 2018-07-04T14:18:07+00:00 https://www.pharmaceutical-business-review.com/news/11482merck_migraine_drug_superior_over_placebo_in_/ 2018-07-04T14:18:08+00:00 https://www.pharmaceutical-business-review.com/news/c3493genzyme_to_construct_new_facility_for_thymoglo/ 2018-07-04T14:18:08+00:00 https://www.pharmaceutical-business-review.com/news/034bapositive_preclinical_results_for_mymetics_hiv_va/ 2018-07-04T14:18:09+00:00 https://www.pharmaceutical-business-review.com/news/d04b6indevus_testosterone_drug_meets_trial_/ 2018-07-04T14:18:09+00:00 https://www.pharmaceutical-business-review.com/news/7c4a1labopharm_starts_phase_iii_antidepressant_/ 2018-07-04T14:18:09+00:00 https://www.pharmaceutical-business-review.com/news/b44bcantisoma_receives_75_million_payment_from_nov/ 2018-07-04T14:18:10+00:00 https://www.pharmaceutical-business-review.com/news/7d48bteva_starts_phase_iii_trial_for_ms/ 2018-07-04T14:18:10+00:00 https://www.pharmaceutical-business-review.com/news/ac49dnew_alzheimers_gene_discovered_in_genetic_marker_/ 2018-07-04T14:18:13+00:00 https://www.pharmaceutical-business-review.com/news/214aaneurogesx_reports_positive_results_for_pain_relief_/ 2018-07-04T14:18:13+00:00 https://www.pharmaceutical-business-review.com/news/d44aealbuferon_as_effective_as_pegasys_says_human_genome_sci/ 2018-07-04T14:18:13+00:00 https://www.pharmaceutical-business-review.com/news/42490aspreva_lupus_treatment_fasttracked_b/ 2018-07-04T14:18:13+00:00 https://www.pharmaceutical-business-review.com/news/e44acpositive_results_for_sangamos_hiv_therapy_in_animal_/ 2018-07-04T14:18:13+00:00 https://www.pharmaceutical-business-review.com/news/3c4batakedas_actos_to_include_black_box_heart_wa/ 2018-07-04T14:18:16+00:00 https://www.pharmaceutical-business-review.com/news/8c482roche_recalls_viracept_due_to_chemical_imp/ 2018-07-04T14:18:16+00:00 https://www.pharmaceutical-business-review.com/news/d048ejohnson__johnson_submits_nda_for_antib/ 2018-07-04T14:18:17+00:00 https://www.pharmaceutical-business-review.com/news/be482accorda_enrolls_first_patient_in_phase_iii_ms_/ 2018-07-04T14:18:17+00:00 https://www.pharmaceutical-business-review.com/news/a34afxtl_stops_drug_development_after_study_re/ 2018-07-04T14:18:17+00:00 https://www.pharmaceutical-business-review.com/news/70487researchers_turn_to_stem_cell_therapy_for_amd/ 2018-07-04T14:18:21+00:00 https://www.pharmaceutical-business-review.com/news/d14abidm_reports_encouraging_results_for_cancer_va/ 2018-07-04T14:18:21+00:00 https://www.pharmaceutical-business-review.com/news/5c488bioms_enrolls_first_patients_in_ms_/ 2018-07-04T14:18:21+00:00 https://www.pharmaceutical-business-review.com/news/0b4baresults_support_further_testing_of_gsk_cancer_va/ 2018-07-04T14:18:21+00:00 https://www.pharmaceutical-business-review.com/news/9f4b8enzo_acquires_axxora_for_163_mi/ 2018-07-04T14:18:22+00:00 https://www.pharmaceutical-business-review.com/news/3049ainovio_halts_enrollment_in_cancer_/ 2018-07-04T14:18:25+00:00 https://www.pharmaceutical-business-review.com/news/9b4b3apt_and_novartis_enter_licensing_agre/ 2018-07-04T14:18:25+00:00 https://www.pharmaceutical-business-review.com/news/f3498valeant_sells_manufacturing_facilities_to_l/ 2018-07-04T14:18:25+00:00 https://www.pharmaceutical-business-review.com/news/1d49aeurand_to_receive_1_million_milestone_fro/ 2018-07-04T14:18:25+00:00 https://www.pharmaceutical-business-review.com/news/d34a1novartis_starts_phase_iii_trial_for_osteoarthritis/ 2018-07-04T14:18:26+00:00 https://www.pharmaceutical-business-review.com/news/75490dsm_and_crucell_license_antibody_technology_to_sart/ 2018-07-04T14:18:30+00:00 https://www.pharmaceutical-business-review.com/news/9f4a2nexavar_extends_liver_cancer_survival_in_phase_iii_/ 2018-07-04T14:18:30+00:00 https://www.pharmaceutical-business-review.com/news/c84a1corautus_stockholders_approve_merger_with_via_pharmaceut/ 2018-07-04T14:18:30+00:00 https://www.pharmaceutical-business-review.com/news/7f4bagsk_posts_promising_longterm_bexxar/ 2018-07-04T14:18:30+00:00 https://www.pharmaceutical-business-review.com/news/8a493pfizer_details_plans_for_key_cancer_comp/ 2018-07-04T14:18:31+00:00 https://www.pharmaceutical-business-review.com/news/83488genentech_posts_updated_survival_data_from_pivotal_herceptin_st/ 2018-07-04T14:18:32+00:00 https://www.pharmaceutical-business-review.com/news/7d495canfite_completes_cf101_longterm_toxicology_st/ 2018-07-04T14:18:33+00:00 https://www.pharmaceutical-business-review.com/news/2b4bbym_biosciences_gets_approval_for_canadian_colorectal_cancer_/ 2018-07-04T14:18:33+00:00 https://www.pharmaceutical-business-review.com/news/3e484barr_and_lilly_dismiss_prozac_weekly_litig/ 2018-07-04T14:18:33+00:00 https://www.pharmaceutical-business-review.com/news/f14b6hemispherx_unveils_positive_influenza_data_for_amp/ 2018-07-04T14:18:33+00:00 https://www.pharmaceutical-business-review.com/news/9249fgsk_progressing_with_nps_calcilytics_pr/ 2018-07-04T14:18:38+00:00 https://www.pharmaceutical-business-review.com/news/ef49everona_pharma_to_start_preclinical_studies_on_hay_fever/ 2018-07-04T14:18:38+00:00 https://www.pharmaceutical-business-review.com/news/6c498studies_show_cipralex_is_superior_to_dulox/ 2018-07-04T14:18:38+00:00 https://www.pharmaceutical-business-review.com/news/c24b2diachrome_found_to_improve_blood_sugar_control_in_type_2_dia/ 2018-07-04T14:18:39+00:00 https://www.pharmaceutical-business-review.com/news/bf49fcardiome_and_astellas_see_positive_results_from_act_2_/ 2018-07-04T14:18:39+00:00 https://www.pharmaceutical-business-review.com/news/2548ebavarian_nordic_wins_us_smallpox_vaccine_con/ 2018-07-04T14:18:40+00:00 https://www.pharmaceutical-business-review.com/news/c74afcyclacel_cancer_candidate_shows_promising_re/ 2018-07-04T14:18:40+00:00 https://www.pharmaceutical-business-review.com/news/4748fvelcade_could_be_offered_o/ 2018-07-04T14:18:41+00:00 https://www.pharmaceutical-business-review.com/news/384b7targeted_genetics_releases_promising_arthritis_drug/ 2018-07-04T14:18:41+00:00 https://www.pharmaceutical-business-review.com/news/c34acgemzar_shows_efficacy_in_breast_cancer_says_eli_/ 2018-07-04T14:18:41+00:00 https://www.pharmaceutical-business-review.com/news/1b4abtransgene_highlights_progress_of_cancer/ 2018-07-04T14:18:44+00:00 https://www.pharmaceutical-business-review.com/news/a74bbbionovo_reports_encouraging_data_for_menopause/ 2018-07-04T14:18:44+00:00 https://www.pharmaceutical-business-review.com/news/b44b9biogenex_settles_lawsuit_with_ve/ 2018-07-04T14:18:44+00:00 https://www.pharmaceutical-business-review.com/news/f64a5pharmacyclics_reports_positive_lung_cancer_drug_re/ 2018-07-04T14:18:44+00:00 https://www.pharmaceutical-business-review.com/news/df4adavastin_plus_interferon_meets_kidney_cancer_trial/ 2018-07-04T14:18:44+00:00 https://www.pharmaceutical-business-review.com/news/984b8ziopharm_cleared_to_trial_oral_arsenic_cancer_trea/ 2018-07-04T14:18:47+00:00 https://www.pharmaceutical-business-review.com/news/ec4a8positive_results_for_peregrines_cancer_treatment_rep/ 2018-07-04T14:18:47+00:00 https://www.pharmaceutical-business-review.com/news/5c495amarillo_to_trial_hepatitis_c_th/ 2018-07-04T14:18:47+00:00 https://www.pharmaceutical-business-review.com/news/7c481fda_to_accept_interim_data_on_dendreons_pro/ 2018-07-04T14:18:47+00:00 https://www.pharmaceutical-business-review.com/news/bb4b9point_therapeutics_cuts_workforce_following_failed_/ 2018-07-04T14:18:48+00:00 https://www.pharmaceutical-business-review.com/news/ab4a9indevus_closer_to_marketing_authorization_for_ventas_in_e/ 2018-07-04T14:18:49+00:00 https://www.pharmaceutical-business-review.com/news/f3492cervarix_to_receive_standard_review_fro/ 2018-07-04T14:18:49+00:00 https://www.pharmaceutical-business-review.com/news/a8489fda_clears_critical_therapeutics_asthma/ 2018-07-04T14:18:49+00:00 https://www.pharmaceutical-business-review.com/news/a84baatherogenics_plans_phase_iii_trial_for_diabetes/ 2018-07-04T14:18:50+00:00 https://www.pharmaceutical-business-review.com/news/e1488researchers_identify_gene_mutation_for_leu/ 2018-07-04T14:18:50+00:00 https://www.pharmaceutical-business-review.com/news/8c488uk_body_recommends_pfizers_quit_smoking/ 2018-07-04T14:18:53+00:00 https://www.pharmaceutical-business-review.com/news/66495novacea_boosted_by_prostrate_cancer_drug_deal_with_scheringp/ 2018-07-04T14:18:54+00:00 https://www.pharmaceutical-business-review.com/news/234a0mylan_receives_fda_approval_for_generic_p/ 2018-07-04T14:18:54+00:00 https://www.pharmaceutical-business-review.com/news/9b488cenerx_to_develop_pharmaness_cannabinoid_port/ 2018-07-04T14:18:54+00:00 https://www.pharmaceutical-business-review.com/news/324a3gilead_cystic_fibrosis_treatment_reaches_trial/ 2018-07-04T14:18:54+00:00 https://www.pharmaceutical-business-review.com/news/22490hgs_gsk_initiate_second_phase_iii_trial_of_lupus/ 2018-07-04T14:18:57+00:00 https://www.pharmaceutical-business-review.com/news/ff4a4bradley_pharmaceuticals_receives_management_buyout_/ 2018-07-04T14:18:57+00:00 https://www.pharmaceutical-business-review.com/news/0c4aacelsion_completes_enrollment_in_phase_i_liver_cancer_/ 2018-07-04T14:18:58+00:00 https://www.pharmaceutical-business-review.com/news/5a498biowa_licenses_potelligent_technology_to_t/ 2018-07-04T14:18:58+00:00 https://www.pharmaceutical-business-review.com/news/7e4bfrexahn_to_take_kidney_cancer_drug_into_pha/ 2018-07-04T14:18:58+00:00 https://www.pharmaceutical-business-review.com/news/c34aeexelixis_initiates_midstage_trials_for_lung_cancer/ 2018-07-04T14:19:13+00:00 https://www.pharmaceutical-business-review.com/news/b64a9roche_ordered_to_pay_225_million_in_accutane/ 2018-07-04T14:19:13+00:00 https://www.pharmaceutical-business-review.com/news/1348bmersana_begins_clinical_trials_for_cancer/ 2018-07-04T14:19:13+00:00 https://www.pharmaceutical-business-review.com/news/d1481burnham_licenses_cancer_drug_to_cor/ 2018-07-04T14:19:13+00:00 https://www.pharmaceutical-business-review.com/news/984b2hitech_pharmacal_settles_patent_litigation_with_medp/ 2018-07-04T14:19:13+00:00 https://www.pharmaceutical-business-review.com/news/1d49dpositive_final_data_from_hycamp_phase_ii_trial_in_metastatic_color/ 2018-07-04T14:19:21+00:00 https://www.pharmaceutical-business-review.com/news/cf48clabcorp_licenses_prostate_cancer_detection_techn/ 2018-07-04T14:19:21+00:00 https://www.pharmaceutical-business-review.com/news/b4495impax_set_to_launch_generic_/ 2018-07-04T14:19:21+00:00 https://www.pharmaceutical-business-review.com/news/0e495dpharm_data_shows_stroke_drug_doubles_recovery_ch/ 2018-07-04T14:19:21+00:00 https://www.pharmaceutical-business-review.com/news/484abranbaxy_acquires_13_dermatology_products_from_bristol/ 2018-07-04T14:19:21+00:00 https://www.pharmaceutical-business-review.com/news/f849fextended_approval_of_flumist_delayed_on_plant_compliance_i/ 2018-07-04T14:19:31+00:00 https://www.pharmaceutical-business-review.com/news/c64aegenzyme_acquires_bioenvision_for_345_mi/ 2018-07-04T14:19:32+00:00 https://www.pharmaceutical-business-review.com/news/3b488fda_to_review_tysabri_for_the_treatment_of_crohns_di/ 2018-07-04T14:19:32+00:00 https://www.pharmaceutical-business-review.com/news/f34b3entremed_starts_phase_ii_brain_cancer_/ 2018-07-04T14:19:32+00:00 https://www.pharmaceutical-business-review.com/news/jj_says_adhd_drug_has_less_abuserelated_effects/ 2018-07-04T14:19:32+00:00 https://www.pharmaceutical-business-review.com/news/3c49dnovagali_pharma_receives_orphan_drug_designation_for_ve/ 2018-07-04T14:19:37+00:00